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Polymer-based drug delivery systems offer the potential to increase the 
bioavailability of drug molecules without leaving toxic byproducts in the body. In 
particular, micellar aggregates based on amphiphilic block copolymers (ABPs) consisting 
of a hydrophobic core and a hydrophilic corona can enable the physical encapsulation of 
poorly water-soluble drugs. These micelles possess several advantages as drug delivery 
carriers due to their colloidal stability and tunable sizes with narrow size distribution. In 
addition, their physicochemical properties and small size enable passive tumor targeting 
through the enhanced permeability and retention effect. Also their chemical flexibility 
allows them to be tailored for active targeting. One additional benefit of using ABP-based 
micelles is that they can be engineered to incorporate stimuli-responsive moieties to 
control release of encapsulated drugs as a result of micellar degradation in response to 
external triggers such as pH, thiols and temperature. With this knowledge, ABP micelles 
can be designed with the ability to respond to stimuli that are inherently present in living 
systems and release their payload before being evacuated from the body. Presence of pH 
and redox gradients within the body makes them ideal stimuli in the design and 
development of stimuli-responsive degradable micelles for controlled release of 
therapeutics. 
For better understanding of the structure-property relationship between 
morphological variance and stimuli-responsive degradation, we have developed new pH-
sensitive degradable micelles having pendant t-butyl groups, as well as reductively 
degradable ABP micelles with single disulfide linkages positioned in the center of  
triblock copolymers, or with pendant disulfides positioned on the hydrophobic block. 
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They were synthesized by atom transfer radical polymerization, a dynamic controlled 
radical polymerization method enabling the synthesis of copolymers with narrow 
molecular weight distributions and pre-determined molecular weights. Aqueous self-
assembly of ABPs resulted in colloidally stable spherical micelles capable of 
encapsulating hydrophobic model drugs at above critical micellar concentration. Various 
analytical methods were used to characterize ABPs and their micelles. The resulting 
micelles in aqueous solutions were destabilized in response to acidic conditions or 
reductive conditions, which suggests the possibility of enhanced release of encapsulated 
compounds. Results show that degradable ABPs of varying architectures and designs, 
upon the proper stimuli, will be dissociated at different rates, leading to a wide range of 
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1.1. Brief overview of the research 
My master research is aimed at developing self-assembled micellar aggregates of 
well-controlled amphiphilic block copolymers (ABPs) with stimuli-responsive 
degradation (SRD) properties. In response to external stimuli these micelles exhibit 
enhanced release of encapsulated biomolecules including anticancer drugs, thus offering 
versatility as multi-functional drug delivery nanocarriers. Several of new ABPs having 
disulfide and pendant acid-labile linkages were synthesized by atom transfer radical 
polymerization (ATRP). They were then characterized for aqueous micellization, 
controlled release and cellular interactions. 
1.2. Drug delivery in general 
1.2.1. Pharmacokinetics of drug delivery 
The science of drug delivery can be described as the application of chemical or 
biological science to control in vivo location of drug molecules for clinical benefits. 
Figure 1.1 illustrates the release profile of drugs by conventional delivery methods such 
as injection. When drugs are administrated the drug level abruptly reaches a peak in the 
blood. However, most of the dose is wasted as only a small fraction of the dose actually 
hits relevant receptors over time. The drug level then decreases to below the minimum 





 The ideal pharmacokinetics of drug delivery suggests that sustainable 
release where drug level in the blood remains constant in the appropriate therapeutic 
range (solid line) between the maximum toxic threshold, and the minimum therapeutic 
level would be beneficial compared with conventional drug administrative methods.
[2]
 
Effective drug delivery systems (DDS) can offer the ability to maintain the therapeutic 
dosage within a target zone. 
 




1.2.2. Routes to elimination of drugs from the body 
Renal excretion and uptake by reticuloendothelial system (RES) are the main 
routes to the elimination of foreign particles from the body. Renal excretion is the 
irreversible transfer from plasma into urine. This minor issue can be minimized by 
designing nanocarriers larger than a certain size ( > 8 nm).
[3]
 RES macrophages are the 
major barrier for the rapid clearance of foreign bodies including drugs from the body 
after intravenous (IV) administration. Typical macrophages include Kupffer cells in the 
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liver and fixed macrophages in the spleen, which recognize opsonin proteins.
[4]
 Opsonins 
are the blood proteins that help macrophages recognize foreign bodies in the blood.
[5]
 
DDS coated with opsonins are removed from blood circulation through a process known 
as opsonization. The extent of opsonization is influenced by size and surface properties of 




1.2.3. Drug targeting strategies 
The idea of drug targeting was suggested nearly 100 years ago by Paul Ehrlich, 
who proposed a hypothetical ‘magic bullet’ to improve drug delivery in the body.[7] There 
are two strategies to deliver drugs to specific sites: “passive” and “active” targeting 
(Figure 1.2). Passive targeting involves the accumulation of particles with diameters < 
200 nm in tumors.
[8]
 This process is known to be the enhanced permeability and retention 
(EPR) effect,
[9]
 utilizing poorly-aligned defective endothelial cells with leaky vasculature. 
More promising is active targeting that uses specific biological interactions, typically 
ligand-receptor and antibody-antigen interactions. This strategy requires the synthesis of 
nanocarriers having functional groups that are utilized for further bioconjugation with 
cell-targeting species such as peptides, proteins, and antibodies. These biomolecules can 
recognize receptors over-expressed on specific tumors, facilitating internalization of 











1.3. Polymeric-based drug delivery nanocarriers 
Polymer-based DDS offer great potential to increase bioavailability of drug 
molecules in vivo. They can effectively deliver drugs to targeted sites, thus increasing 
therapeutic efficiencies.
[11]











Polymer-drug conjugates are called polymer-prodrugs in which drugs are 
chemically linked to polymers. The polymer-prodrugs can increase water solubility of 
hydrophobic drugs as well as promote the transport of drugs to targeted areas.
[16]
 
However, a drawback involves the use of covalent linkages to conjugate drug molecules 
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to polymer chains. These stable bonds are not easily cleaved to release drugs. To 
circumvent this issue, labile linkages such as disulfides have been used.
[17]
 
Dendrimers are well-defined highly branched macromolecules. Typical examples 
include polyamidoamine (PAMAM) modified with neutral moieties,
[18]
 polyaryl ether 
and poly(ethylene oxide) (PEO)-based dendrimers.
[19]
 They exhibit unique morphological 
and physical properties, high biocompatibility and water solubility, thus offering potential 
as candidates for polymer-based DDS. However, the synthesis of well-defined multi-
generation dendrimers remains challenging. 
Microgels are a class of hydrogels that are submicron sized crosslinked particles. 
When the size of microgels is in a nanometer range, they are known as nanogels. These 
microgels/nanogels possess all features of hydrogels, including tunable chemical and 
physical structures, good mechanical properties, high water content and biocompatibility. 
Further, they exhibit tunable size, large surface area for bioconjugation, and hydrophilic 
interior network.
[20]
 They are suitable for encapsulation of hydrophilic drugs. 
My thesis focuses on the design and development of effective micellar aggregates 
based on amphiphilic block copolymers (ABPs), which will be explained in greater 
detail.  
1.4. Amphiphilic block copolymer micellar aggregates 
In recent years, ABP-based micelles have been extensively explored for 
pharmaceutical applications. The rapid development of ABP-based micelles is because of 
their ability to form various types of nanoparticles with desirable properties as effective 
drug nanocarriers. These promising properties of ABPs are initiated as a result of their 
chemical flexibility and ability to form nanostructure with various morphologies.  
 6 
 
ABPs consist of covalently attached hydrophobic and hydrophilic blocks, which 
can be obtained by polymerization of more than one type of monomers. Typical polymers 
include polyesters,
[21]
 poly(amino acid) derivatives,
[22]
 and polymethacrylate as 
hydrophobic block hydrophilic blocks; and PEO, PEO analogues, and polysaccharides as 
hydrophilic block.
[23]
 As a result of the amphiphilic nature, ABPs undergo self-assembly 
to form micellar aggregates with various morphologies in aqueous solution. This is to 
minimize energetically unfavorable interaction of hydrophobic surfaces with water.
[24]
 
These morphologies are dictated by “packing parameter (P)”, as defined by the 
following equation: 
   
 
    
  
Where “v” is the volume of hydrophobic chains, “a0” is area of the hydrophilic head 
group and “lc” is the length of hydrophobic tail. As seen in Figure 1.3, P values determine 
the favored morphologies of aggregates: P ≤   ⁄  formation for spherical micelles, 
 
 ⁄  ≤ 
P ≤   ⁄  for cylindrical micelles, and 
 













 Self-assembled micelles consist of hydrophobic cores, ensuring encapsulation of 
hydrophobic therapeutics including anticancer drugs, surrounded with hydrophilic 
coronas, enduring biocompatibility and aqueous colloidal stability (Figure 1.4).
[26]
 In 
addition to these features, they possess several advantages; including facile preparation, 
colloidal stability, tunable sizes with narrow size distribution, as well as protection of 
drugs from deactivation, preservation of its activity during blood circulation and transport 
to targeted area. Their physicochemical properties and small size enables passive tumor 
targeting through the EPR effect,
[27]
 and further they can enhance drug efficiency through 
active targeting by bioconjugation. For successful applications, a high degree of control 









1.4.1. Micelle stability 
The stability of micellar systems can be evaluated in terms of thermodynamic and 
kinetic stability. Thermodynamic stability of micelles reflects how micelles form or 
dissociate at different concentrations. From this point of view, micelle stability can be 
measured by critical micellar concentration (CMC), which is the concentration at which 
micellar aggregates first appear. At concentrations below CMC, the existence of polymer 
chains as unimers or single polymer chains is thermodynamically favored. Upon the 
increase in concentrations above the CMC, polymer chains prefer to spontaneously self-
assemble into micelles to minimize enthalpically less favourable interactions between the 
hydrophobic segments and water  (Figure 1.5).
[29]
  
The important parameters that influence CMC values include the composition of block 
copolymers; such as chain length, chemical structure/interaction parameters between the 
different blocks and water, as well as cross-linking of block segments. For example, an 
increase in hydrophobic chain length decreases CMC, due to greater energy minimization 
when hydrophobic chains assemble.
[30]













 The low CMC is advantageous for in vivo applications, in that micelles are 
stable upon dilution in blood. 
  
 
Figure 1.5. Schematic illustration of the process of micelle formation and the concept of 
CMC. 
 
The kinetic stability of a polymer micelle undergo extremely different processes 
in assembly and disassembly.
[32]
 For copolymer micelles the nature of the hydrophobic 
core plays an important role in the kinetic stability. In micelles that exist in environments 
that are below the glass transition temperature of the core forming polymer, the core of 
the micelle can be a solid matrix, which would lead to high kinetic stability. The polymer 
chains in this matrix are essentially immobile and so even when the micelle falls below 
the CMC, chain mobility is limited and the micelle cannot easily disassemble. So the 
mobility of the polymer chains, which is Tg dependent, and the degree of entanglement, 
which is length dependent, are extremely important in tailoring the kinetic stability of a 
micelle.
[33]
 Another factor that can play an important role in the kinetic stability is the 
amount of solvent in the core, which can aid in chain mobility and suppress the Tg. Also 
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the kinetic stability of micelles depends on the size of hydrophobic block and mass ratio 
of hydrophilic to hydrophobic blocks.
[34]
 
1.4.2. Micelle size 
Micelle size is an important property which largely influences the circulation time 
and organ distribution of DDSs. The size of micelles is controlled by several factors such 
as the length of core forming block and corona forming block.
[34]
 Polymer based DDS 
usually range in size from 10 to 100 nm, and as such are less susceptible to RES 
clearance. They are also small enough to pass through small capillaries in the body (those 
less than 5 µm), giving them access to small capillaries.
[35]
 Further, their size falls within 
the optimal range for circulation and retention within tumor tissue by the EPR effect.  
1.5. Stimuli-responsive degradation (SRD) strategy  
Advanced techniques allow for the synthesis of ABPs with chemical flexibility 
which can be engineered to incorporate stimuli-responsive degradable moieties. These 
degradable covalent linkages make nanocarriers capable of undergoing changes in one or 
more physical properties in response to external triggers; thereby triggering the 
programmed release of encapsulated biomolecules, particularly anticancer therapeutics 
(Figure 1.6) while facilitating the removal of empty vehicles after release. This stimuli 
may either be physiological (i.e. pH, thiols or specific enzymes) or physical stimuli (i.e. 
heat, light and ultrasound).
[36]
 After micellar dissociation in response to proper stimuli 
which can be unique to disease pathology, ABP unimers which fall below the glomerular 









As seen in Figure 1.7, there are typically four different strategies to design 
micelles with stimuli-responsive moieties. Based upon the number and location of 
cleavable linkage (X), they divide to multi-cleavable (A and B) or mono-cleavable 
micelles (C and D). In addition, the cleavable linkages (X) are located either in their 





Figure 1.7. Stimuli responsive ABP micelles with different location of cleavable linkage 
(X). The figure is slightly modified from the reference (A and B represent polymer 




Pendant multi-cleavable micelles are formed through self-assembly of ABPs 
having pendant cleavable linkages positioned in the hydrophobic blocks (XpA-b-B).
[38]
 In 
response to external stimuli, they are destabilized upon the cleavage of pendant 
degradable groups that increases polarity of hydrophobic blocks. Backbone multi-
cleavable micelles have multiple cleavable linkages positioned regularly in the 
hydrophobic polymer main chains (XbA-b-B).
[39]
 Mono-cleavable micelles are based on 
amphiphilic triblock copolymers having single cleavage linkages in the middle (B-b-A-
X-A-b-B).
[40]
 Both backbone multi-cleavable and mono-cleavable micelles are degraded 
through the loss of hydrophobic cores. For mono-cleavable micelles, the degraded 
polymers are still amphiphilic, and thus could re-aggregate to smaller-sized assembled 
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structures. While all these type of micelles are designed to have cleavable linkages in the 
hydrophobic cores, sheddable micelles contain cleavable linkages at the interfaces of 




In the following section, the development of pH and thiol-responsive degradable 
block copolymer micelles are reviewed which are of interests to my research.  
1.5.1. pH-responsive degradable micelles 
pH-sensitive systems have been widely studied because of pH gradients within 
the body.
[41]
 For example, at organ level, along gastrointestinal (GI) tract, pH changes 
from acidic in the stomach (pH = 2) to more basic in the intestine (pH > 7). At tissue 
level, tumor tissue exhibits slightly acidic pH (5.0 to 6.5). In the subcellular compartment 
level, endosomes and lysosomes are also in acidic pH (5.0 to 5.5).
[41]
 While stable in 
normal physiological conditions, pH-sensitive degradable micelles are destabilized in 
acidic environment leading to site-specific release of encapsulated drugs in a controlled 
manner. The sensitivity of pH-responsive ABP micelles results from their “titratable” 
groups (pKa from 3-11), which undergoes ionization upon changing the pH
[42]
 or from 
their labile linkages which are cleaved under mild acidic conditions ( pH < 6). Table 1.1, 










































Extensive studies have been done on the development of pH-responsive 
degradable micelles. To obtain acid-responsive degradable micelles, different acid labile 
linkages such as orthoester, hydrazone, cis-acotinyl and acetal have been positioned 
either in the main chain, at the side chain, or at the terminal of core forming block.
[50]
  
Several examples of acid-responsive degradable micelles have been reported. Acid-
sensitive ABPs, composed of PEO as the shell forming block and polycarbonate (PC) 
block having pendant orthoester groups as core forming block (PEO-b-PC) have been 
synthesized. The self-assembled micelles of PEO-b-PC degraded in acidic pH to the 
corresponding hydroxyl polycarbonates.
[51]
 Attachment of hydrophobic drugs via acid 
sensitive linkages to the core forming block of a copolymer is another strategy for 
developing pH-sensitive DDS.
[52]
 In this system cleavage of the linkage facilitates drug 
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release. For example pH-sensitive drug delivery nanocarriers was developed by 
conjugating doxorubicin (DOX) to the end group of PEG-PLA through an acid sensitive 
hydrazone or  cis-aconityl bond.
[53]
 pH-sensitivity of cis-aconityl bonds was actually 10 
times higher than hydrazone linkages, but cleavage of this linkage form chemically 
modified DOX after release; whereas through cleavage of hydrazone bonds, DOX could 
be released without any change in therapeutic properties. Also another acid-sensitive 
ABP micelle was developed by grafting DOX to a PEO-polyaspartate through hydrazone 
linkages. Upon cleavage of hydrazone linkages, the release of DOX was enhanced when 
decreasing the pH value from 7.4 to 3.0.
[54]
 Recently acetals as acid-labile linkages have 
been exploited for design of pH-responsive micelles.
[49]
 In particular, 
trimethoxybenzylidene acetals attached either to the side chain of poly(aspartic acid) 
(PAA) segment of PEG-PAA block copolymers
[49]
 or to the periphery of dendron of 
PEG-dendritic block copolymers showed unique sensitivity toward mildly acidic pH.
[52]
 
Micellar aggregates were effectively disrupted due to the hydrolysis of acetals and thus 
enhanced release of encapsulated Nile Red (NR)  or DOX under mildly acidic conditions. 
1.5.2. Redox-responsive degradable micelles 
The existence of reduction potential gradients between intracellular and 
extracellular compartments makes reductive electron transfer an ideal stimulus in design 
and development of redox-responsive degradable nanomaterials for drug delivery 
applications.
[55]
 Disulfides are cleaved in reducing environments or through disulfide-
thiol exchange reaction. Disulfide-thiol chemistry is especially applicable for in vivo drug 
delivery applications due to the presence of  glutathione (GSH), a low molecular weight 
tripeptide containing a pendant thiol group that is found in extracellular fluids at a 
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concentration of ≈10 µM.[56] GSH exist at higher level in cytosol (≈10 mM).[57] More 
importantly, the cytosolic level of GSH in some tumor cells is several times higher than 
in normal cells.
[58]
 This large difference in GSH concentration between healthy and 
cancerous cells can be used to selectively deliver anti-cancer therapeutics to affected 
areas.  
A number of disulfide-containing polymeric micelles have been extensively 
explored as controlled delivery nanocarriers of anticancer drugs. For example, disruption 
of a shell-sheddable micelle consisting of poly(ethylene glycol)-ss-poly(ε-caprolactone) 
(PEG-ss-PCL) in a reductive environment resulted in 60% DOX release within 4 hrs, as 
compared to 20% DOX release over one month from PEG-b-PCL.
[59]
 Also recently, 
dextran-block-poly(ε-caprolactone) diblock copolymers containing a disulfide bond 
between hydrophilic and hydrophobic segments was developed. In the absence of a 
reducing environment, only 27% of the loaded DOX was released over 11 hrs, as 
compared to almost 100% discharge in a reducing environment.
[60]
 In a very similar case, 
a thiol-responsive shell detachable block copolymer composed of PCL block and 
poly(ethyl ethylene phosphate) (PEEP) block having single disulfide in middle of blocks 
(PCL-ss-PEEP) was synthesized. The PCL-ss-PEEP micelles exhibited the fast cleavage 
of disulfide linkages in response to GSH, taking 2 hrs to reach almost complete drug 
release.
[61]
 Redox-responsive micelles formed from hyperbranched multi-arm 
copolyphosphates having disulfides were synthesized. The disulfide linkages were 
cleaved in the presence of dithiothreitol (DTT), enhancing the release of encapsulated 
DOX.
[62]
 Thiol-responsive micelles of poly(amido-amine) labeled with disulfides and 
grafted with PEO exhibited the slow cleavage of disulfide linkages in response to DTT, 
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taking > 120 hrs to reach > 80% degradation.
[39]
 Redox-responsive micelles based on 
polyester-based polymethacrylate ABPs (ssPES-b-POEOMA or ssABPs, OEOMA: 
oligo(ethylene glycol) monomethyl ether methacrylate) having disulfide linkages 
repeatedly positioned on polyester backbones (ssPES) were synthesized. The reductive 
cleavage of disulfide linkages in reducing conditions resulted in the degradation of ssPES 
homopolymers. With the increasing amounts of disulfide linkages in ssPES–OH and 
reducing agents their degradation rate was significantly enhanced.
[63]
  
In order to increase the stability of micelles against premature dissociation of 
micelles, cross-linked micelles have been developed. However, such a covalent 
crosslinking strategy can limit the release rate of encapsulated drugs. In order to 
overcome this drawback, introduction of stimuli-responsive cleavable linkages have been 
proposed. Recently, a block copolymer consisting of pendant disulfide-labeled 
methacrylate (PHMssEt) and PEO (PEO-b-PHMssEt) was synthesized. This copolymer 
self-assembled to form micellar aggregates, which can undergo disulfide core-
crosslinking in the presence of catalytic amounts of DTT (< 1 eq). Micelles were 
destabilized and released the NR by increasing the concentration of DTT (5 eq DTT).
[64]
  
The brief review of literatures demonstrates that stimuli-responsive degradable 
micelles can be made as successful proof of concepts. These examples are merely a 
glance at the various numbers of novel and efficient strategies to synthesize versatile 
stimuli-responsive degradable micelles toward drug delivery. Smart micelles can be made 
from surprisingly simple polymers, although this may be due to a reluctance to utilize 
more complex polymeric structures due to fear of unknown toxicity and regulatory 
delays. Standardization of polymers used might actually aid in commercialization, as 
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more effort will be devoted to finding a simple synthesis process, making it easier to 
make micelles that meet current good manufacturing practices. Regardless of all the 
improvements in the design of stimuli-responsive degradable micelles as DDSs, there is 
still a need to better understand the structure–property relationship between 
morphological variance and stimuli-responsive degradation in order to optimize the 
design of polymeric nanocarriers. A more thorough understanding of the use and 
placement of different stimuli responsive degradation triggers will help promote the 
efficiency of DDSs. In addition, implementation of more precise triggers, such as those 
which response to specific biomolecules will further enhance the effectiveness of targeted 
delivery, and is an ongoing area of research. 
1.6. Scope of the thesis 
My master research will be presented in the following four chapters. Chapter 2 
describes the methodology for the synthesis and characterization of stimuli-responsive 
degradable ABPs and their self-assembled structures, as well as their cellular interactions.  
Chapter 3 is devoted to the synthesis of a hydroxyl-terminated pH-responsive 
degradable ABPs and evaluation of its effectiveness as micellar drug carriers. Well-
defined hydroxyl-terminated poly(oligo(ethylene oxide) monomethyl ether 
methacrylate)-b-poly(t-butyl methacrylate) (OH-POEOMA-b-PtBMA) was synthesized. 
The pendant tert-butyl groups of these ABPs were cleaved in acidic conditions, resulting 
in pH-triggered destabilization of the micelles in aqueous solution. Their facile 
bioconjugation was demonstrated by conjugation with biotin. The competitive assay 




Chapter 4 explores a novel brush-like triblock copolymers consisting of a 
hydrophobic polymethacrylate block having pendant oligo(propylene oxide) and a 
hydrophilic polymethacrylate block having pendant oligo(ethylene oxide) (ss-(PAP-b-
POEOMA)2). Thiol-responsive disulfide linkages were positioned in the middle of the 
triblock copolymers, thus resulting in the formation of the mono-cleavable micelles by 
self-assembly in aqueous solution.  The cleavage of the disulfide linkages in micellar 
cores in response to thiols resulted in dissociation of micelles to smaller-sized assembled 
structures in water. 
Chapter 5 describes self-assembly of a thiol-responsive pendant multi-cleavable 
micelles consisting of a pendant disulfide-labeled polymethacrylate core (PHMssEt) and 
a hydrophilic poly(ethylene oxide) (PEO) corona (PEO-b-PHMssEt) block copolymer. In 
response to cellular GSH, the cleavage of pendant disulfide linkages of these PEO-b-
PHMssEt ABPs resulted in the destabilization of these micelles, which enhanced the 
release of encapsulated doxorubicin (DOX) of anticancer drug. Their cellular interactions 
including intracellular viability after cellular uptake were examined. 








    Methodology: Synthesis and Characterization 
 
2.1.      Brief description 
This chapter describes the methodology of synthesis and characterization of well-
defined amphiphilic block copolymers (ABPs) and their aqueous micellar aggregates for 
biological and biomedical applications. Different techniques and instruments employed in 
my research are also briefly described. The detailed experimental procedure for chapter 3, 
4 and 5 are summarized in appendix A, B and C. 
2.2.      Synthesis and characterization of well-defined ABPs  
2.2.1 ATRP as a means to synthesize well-defined ABPs 
In order to synthesize polymers with complex macromolecular architectures such 
as block copolymers for drug delivery applications, it is crucial to have strict control over 
molecular weight, molecular weight distribution, and chemical composition of polymer 
chains. Traditionally, living anionic polymerization has allowed for synthesis of well-
controlled block copolymers with narrow molecular weight distribution (Mw/Mn < 
1.1).
[65]
 This polymerization requires the growth of all polymer chains at the same time 
with no undesirable side reactions such as chain transfer or irreversible termination.
[66]
 
However, carbon-centered terminal anions exhibit a high sensitivity to traces of 
impurities. Such high sensitivity renders anionic polymerization incompatible with 
several functional monomers and is difficult to implement industrially. Alternatively, 
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controlled radical polymerization (CRP) techniques have been recently developed, 
combining the control of anionic polymerization as well as the versatility of conventional 
free radical polymerization. They work based upon two main principles: (1) reversible 
termination, as demonstrated by nitroxide-mediated polymerization (NMP)
[67]
 and atom 
transfer radical polymerization (ATRP);
[68]
 and (2) reversible transfer, utilized in 
reversible addition fragmentation chain transfer (RAFT) polymerization.
[69]
 In this thesis, 
most block copolymers were synthesized by ATRP. 
ATRP was independently discovered by Mitsuo Sawamoto
[70]
 and Krzysztof 
Matyjaszewski
[68]
 in 1995. This technique works through the end-capping of a polymer 
chain with halogen which can reversibly undergo homolytic cleavage (Figure 2.1). The 
mechanism of normal ATRP involves the transfer of halogen atoms from dormant 
polymer chains (Pn-X) to transition metal complexes (Cu(I)/L) as activators, yielding 
active chain ends (Pn* radicals) and deactivators (X-Cu(II)/L). These (Pn*) radicals 
species can undergo propagation with the rate constant of propagation (kp), to grow 
polymeric chains. Alternatively, the radical species can be deactivated by halogen 
transfer from deactivators to yield dormant species (Pn-X). This reversible equilibrium 
process of activation and deactivation is shifted towards deactivation, as the rate constant 
of deactivation is much larger than the rate constant of activation (kdeact >> kact). This 
shift can minimize the concentration of radicals and chain transfer reactions, thus 




Figure 2.1. Mechanism of normal ATRP process. 
 
 
  One of the key advantages of ATRP for designing various molecular 
architectures and nanostructure morphologies is that the resulting polymer chains retain 
halogen moieties at the chain end. These terminal halogens can facilitate the reactivation 
of the chain end for functionalization or use as macroinitiator for subsequent 
polymerization, resulting in various architectures of block copolymers with 
predetermined molecular weight and narrow molecular weight distribution. Also by 
utilizing functionalized alkyl halides as initiators, along with post polymerization 
modification of the terminal halogen atom, different functionalities can be easily 
introduced to both chain ends.  
In addition to normal ATRP, Activator Generated by Electron Transfer (AGET) is 
a facile variant of ATRP. AGET ATRP provides all the benefits of normal ATRP with 
the additional advantage that  more oxidatively-stable Cu(II) complexes are used in the 
reaction mixture. This process begins with the use of Cu(II) deactivators, which react 
with reducing agents, generating Cu(I) activators. The polymerization then proceeds as in 
normal ATRP conditions with the added alkyl halide. Typical reducing agents include 






Figure 2.2. Mechanism of AGET ATRP process. 
 
 In my research, normal ATRP was conducted in the presence of ATRP initiator, 
monomer, metal catalyst (CuBr(I)), ligand, and proper solvent. The resulting mixture was 
deoxygenated by three freeze-pump-thaw cycles. The reaction flask was filled with 
nitrogen and then CuBr(I) was added to the frozen solution. The flask was sealed, 
evacuated with vacuum and backfilled with nitrogen. The mixture was thawed and the 
flask was then immersed in a preheated oil bath to start the polymerization. The 
polymerization was stopped by exposing the reaction mixture to air.  
 For AGET ATRP, a mixture consisting of ATRP initiator, monomer, oxidatively-
stable metal catalyst (CuBr(II)), ligand, and proper solvent was deoxygenated by purging 
with nitrogen for 30 min at room temperature. The flask was immersed in a preheated oil 
bath. A nitrogen-purged solution of reducing agent (Sn(Oct)2) in solvent was added to 
start the polymerization. The polymerization was stopped by exposing the reaction to air. 
2.2.2.   Molecular weight determination by gel permeation chromatography (GPC) 
The average molecular weight (MW) is a fundamental characteristic of block 
copolymers which dictates most of their properties. The molecular weight of a polymer 
can be defined as the number-averaged molecular weight (Mn) and weight-averaged 
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molecular weight (Mw). Mn is the average molecular weight on the basis of the number of 
molecules (Ni) in a particular weight class (Mi):     ∑    ∑  ⁄ . An average on the 
basis of the weight fraction (Wi) of molecules in a particular weight class (Mi) is Mw: 
    ∑    
  ∑     ⁄ . The ratio of     ⁄  is defined as the polydispersity index 
(PDI) which is a useful indicator of the breadth of the distribution of molecular mass in a 
given polymer sample.           ⁄ . 
Gel permeation chromatography (GPC) is a simple and effective method to 
determine molecular weight of polymers. A typical GPC consist of one or more columns 
packed with porous microparticles of highly crosslinked polymers connected to various 
detectors. A polymer solution is injected into a solvent stream that flows through the 
GPC columns (Figure 2.3). Polymer chains are separated according to their 
hydrodynamic volumes, which is a function of molecular weight and molecular 
conformation in solution and affects the elution time through the columns. Longer 
polymer chains will have a larger hydrodynamic volume, and as such are unable to pass 
through small void spaces in the porous microparticles packed into a separation column. 
This gives longer polymer chains a shorter elution/retention time, while shorter polymer 
chains will possess a longer retention time.   Using detectors typically measuring 
refractive index (RI) or light scattering signals, polymer concentration in the eluent at 
different elution times is detected. A GPC system is calibrated with a series of standard 
samples of known molecular weights to relate elution time with molecular weight or 
intrinsic viscosity. Typical standards include polystyrene (PSt), poly(ethylene glycol), 





Figure 2.3. Schematic diagram of a GPC setup for the measurement of polymer 




In my research, a GPC equipped with a Viscotek VE1122 pump, a RI detector and 
three PolyAnalytik columns (PAS-103L, 105L, 106L, designed to determine molecular 
weight up to 2,000,000 g mol
-1
) were used with THF as an eluent at 30 C at a flow rate 
of 1 mL min
-1
. Linear PMMA standards were used for calibration. Aliquots of polymer 
samples were dissolved in THF and the clear solutions were filtered using a 0.25 µm 
PTFE filter to remove any THF-insoluble species. A drop of anisole was added as a flow 
rate marker.  
2.3.      Aqueous micellization and characterization  
2.3.1. Preparation of micellar aggregates in aqueous solution 
Depending on the physicochemical properties including the solubility of block 
copolymers, there are several methods that allow for the formation of micellar 
 26 
 
aggregates. These methods include direct dissolution, solvent evaporation and dialysis 
method. Direct dissolution involves dissolving copolymer directly in water. This 
procedure is applicable for moderately hydrophobic copolymers.
[24]
 Both, solvent 
evaporation and dialysis methods are accomplished by using organic solvents. The 
solvent evaporation method is based on dissolving block copolymers in a volatile organic 
solvent. Water is then slowly added to the solvent to form micelles, and  evaporation of 
the solvent results in the formation micellar aggregates. The Dialysis method involves 
dissolving copolymers in water miscible organic solvents followed by extensive dialysis 
against water. Eventually, organic solvents are replaced with water, triggering self-
assembly to form micelles.
[73]
  
2.3.2. Determination of critical micellar concentration (CMC) 
CMC is the concentration at which micellar aggregates first appear. At the CMC, 
a distinct transition of several physical properties is observed due to the formation of 
micellar aggregates. Typical methods to determine CMC of block copolymers include 
tensiometry
[74]
 and fluorescence spectroscopy.
[75]
  
Tensiometery utilizes the measure of surface tension of aqueous polymer 
solutions. At low concentrations, the surface tension does not change; however with an 
increasing concentration, it abruptly increases. Upon further increase, the tension slowly 
increases. This increase is visible on a plot of surface pressure versus solution 
concentration. Using this method the CMC is determined as the concentration when the 
transition of pressure occurs. 
Also fluorescence spectroscopy has widely been used to determine the CMC of 
polymeric micelles. Nile Red (NR) is a fluorescent probe typically used to determine 
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CMC. It generally excites at 485 nm and emits at 525 nm. Its fluorescence is strongly 
influenced by the polarity of its environment. In this method, the change in fluorescence 
intensity of NR at various concentrations of the polymer is monitored.
[76]
 This 
characterization method works based upon the fact that as a result of poor water solubility 
of NR, its fluorescence emission is significantly lower in water; however, when NR is 
entrapped in the hydrophobic micellar core, its fluorescence becomes much more 
intense.
[76]
  The CMC can be easily estimated from changes of the NR fluorescence 
intensity as a function of micellar concentration. The transition onset of fluorescence 
intensity is defined as the CMC. 
In my research, CMC of amphiphilic block copolymers in water have been 
determined using both methods. A DeltaPi Surface Tensiometer from Kibron was 
calibrated using air and water at room temperature and used to measure the change in 
surface tension of different polymer solutions. Alternatively, the fluorescence spectra of 
various polymer solutions containing NR were recorded on a Varian Cary Eclipse 
fluorescence spectrometer.  
2.3.3. Characterization of size and morphology of micellar aggregates 
Dynamic light scattering (DLS) is a common technique for determining the size 
of particles in colloidal dispersions. DLS measures the intensity of light scattered by 
particles in dispersions at a given angle upon radiation of light. Brownian motion of 
particles in solution causes changes in scattered light intensity. Analysis of these intensity 
fluctuations allows for the determination of hydrodynamic diameter of particles through 
the Stokes-Einstein equation.  
 28 
 
    
   
    
   
Where KB is the Boltzmann constant; T is absolute temperature; η is viscosity and 
D is diffusion constant. The diffusion of particles is essentially controlled by temperature, 
viscosity of the solvent and the size of the particles.  If the temperature and solvent are 
constant and known, the variation in the intensity of the scattered light is directly related 
to the “size” of the molecule. The larger the molecules, the slower they move.   
In my research, particle size of micellar aggregates was measured by DLS using 
two different particle size analyzers. Initially a model DynnaPro Titan from Wyatt 
Technology at fixed scattered angle of 90° at 25 °C was used. In this case, DLS 
measurements provide average diameter (Dav), which is defined as follows, Dav =∑Di/N, 
where Di is the diameter of the particle i and N is the total number counted. The bulk of 
the measurements were conducted using a Malvern Instruments Nano S ZEN1600 
equipped with a 633 nm He-Ne gas laser at a fixed scattering angle of 173° at 25 °C. All 
micellar dispersions were filtered by a 0.45 µm polyethersulfone (PES) filter to remove 
large aggregates formed during aqueous micellization.  
Transmission electron microscopy (TEM) is used to study the morphologies of 
micellar aggregates in dehydrated states and can provide an absolute measurement of 
particle size. TEM involves a transmission of a beam of electrons through a dried sample 
in a high-vacuum environment. Regional differences in electron densities give contrast to 
form images.  
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In my research, TEM images were taken using a Philips CM200 HR-TEM, 
operated at 200 kV electrons and equipped with thermionic LaB6 cathode filament, anti-
contamination cold finger, Genesis EDAX system, and AMT V600 2k × 2K CCD 
camera. The point-to-point resolution and the line resolution of the machine are 0.24 nm 
and 0.17 nm, respectively. To prepare specimens, samples were dropped onto the TEM 
copper grids (400 mesh, carbon coated), then grids were dried in air. In this case, particle 
size was analyzed using ImageJ program. 
2.4. Cellular interaction of ABP-based micelles 
2.4.1. Cell viability 
For biomedical applications polymeric materials should be non-toxic to cells. A 
variety of methods to estimate cell viabilities are available ranging  from the most routine 
trypan blue dye exclusion assay to highly complex analysis of individual cells using 
RAMAN microscopy.
[77]
 The cost, speed, and complexity of equipment required play an 
important role in determining the assay used. 
Trypan blue is a simple method to determine cell viability. Trypan blue is 
normally excreted from live cells. If cells take up trypan blue, they are considered non-
viable. Cell viability is calculated as the ratio of number of viable cells to the total 
number of cells within the grids on the counting cell slide (hemocytometer).
[78]
   
Tetrazolium-based assays are standard colorimetric methods, including 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assays. Tetrazolium-based assays have several advantages over other methods, 
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including simplicity, reproducibility and fast data generation.
[79]
 These assays are based 
upon the functionality of the mitochondrial dehydrogenase of viable cells to reduce a 
tetrazolium-based compound. This enzyme is able to cleave the tetrazolium rings of the 
MTT dye and form blue formazan crystals (Figure 2.4) and the MTS dye into water-
soluble formazan product. Dead cells rapidly lose the ability to reduce tetrazolium 
products. The production of the colored formazan products are directly proportional to 








 Figure 2.5 shows the absorption spectra of MTT and MTT-formazan produced by 
incubation of L-DAN cells in presence of MTT. Also absorption spectrum of commercial 
prepared MTT-formazan is shown in Dimethyl sulfoxide (DMSO). Commercial 
formazan (from Sigma) exhibits two absorption maxima at 510 and 570 nm. However, 









Figure 2.5. Absorption spectra of MTT and commercially prepared MTT-formazan 
dissolved in DMSO. Also shown is the spectrum of MTT-formazan produced by 




LIVE/DEAD viability assay is a fluorescence-based method. Calcein AM and 
ethidium homodimer (EthD-1) are optimal fluorescence probes for this assay, which are 
used to measure intracellular esterase activity and plasma membrane integrity.[83] In this 
assay, live cells are distinguished upon the functionality of ubiquitous intracellular 
esterase. This enzyme is able to convert the almost non-fluorescent calcein AM to the 
intensely fluorescent calcein, therefore producing green fluorescence in live cells 
(ex/em ~ 495 nm/ ~ 515 nm). On the other hand, EthD-1 is excreted from live cells and 
enters cells with damaged membranes. Upon binding to nucleic acids, the 
fluorescence intensity of the EthD-1 increases, producing red fluorescence in dead 
cells (ex/em ~ 495 nm / ~ 635 nm).[84] These physical and biochemical properties help 
to determine the cell viability. This assay is generally faster, less expensive, and more 
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accurate than alternative methods. However it is more complicated than tetrazolium-
based assays and requires fluorescence microscope.   
In my research, cell viability was measured using a CellTiter 96 Non-Radioactive 
Cell Proliferation Assay kit (MTT, Promega). Measurements were performed according 
to manufacturer’s instruction. Briefly, MTT solution (15 μL) was added into each well. 
DMSO (100 μL) was added into each well in order to dissolve the formed formazan blue 
crystals, and then the absorbance at λ = 570 nm was recorded using a Powerwave HT 
Microplate Reader (Bio-Tek). Each concentration was repeated 12 times. Cell viability 








      pH-Responsive Degradable Micelles 
 
 
3.1.      Introduction 
pH-sensitive ABP micelles have been widely studied because of pH gradients in 
normal and pathophysiological states.
[41]
 While stable in normal physiological conditions, 
pH-sensitive micelles are destabilized in acidic environments, such as the interior of 
tumors. Such destabilization facilitates the release of encapsulated drugs in a controlled 
manner.
[85]
 Current strategies toward the development of pH-responsive micelles involve 
the synthesis and aqueous micellization of acid-sensitive ABPs. Most these strategies are 
achieved by either incorporating “titratable” groups, such as amines[86] or carboxylic 
acids
[87]
 into the copolymers, or utilizing labile linkages, such as hydrazones
[53]
 or ortho 
esters.
[52]
 The latter is my strategy of interest.  
 A convenient method to prepare pH-responsive degradable micelles involves the 
incorporation of pendant pH-sensitive cleavable groups into a hydrophobic block. 
Hydrolytic cleavage of these groups in acidic environment increases the polarity of the 
hydrophobic block, causing the micelles to be destabilized. The development of acid-
sensitive copolymers consisting of PEO as the hydrophilic block and different 
hydrophobic blocks functionalized with pendant ortho ester moieties have been reported. 
Typical hydrophobic blocks include poly(aspartic acid) (PAA),
[88]





 Despite these advances, the developments of 
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new types of pH-responsive degradable micelles are needed to better understand 
structure-property relationship between morphological variance and pH responsive 
degradation.  
This chapter describes new hydroxyl-terminated ABPs having pendant pH-
sensitive t-butyl groups, consisting of hydrophilic poly(oligo(ethylene oxide) 
monomethyl ether methacrylate) (POEOMA) and hydrophobic poly(t-butyl methacrylate) 
(PtBMA) blocks. These HO-terminated POEOMA-b-PtBMA block copolymers (HO-
ABPs) were synthesized by consecutive atom transfer radical polymerization (ATRP) of 
OEOMA and tBMA in the presence of a HO-functionalized bromine initiator (OH-
iBuBr). Figure 3.1 shows the synthetic scheme and rational design of HO-ABPs as 
potential drug delivery nanocarriers. First, POEOMA was chosen as the hydrophilic 
block because of its high water solubility and as a biocompatible analog of linear PEO, a 
material approved by the FDA for clinical use.
[90]
 Second, PtBMA as core-forming block 
enables the encapsulation of hydrophobic therapeutics. Also it is potentially degradable 
through hydrolytic cleavage of pendant t-butyl groups to water-soluble poly(methacrylic 
acid) (PMAA) in acidic conditions. Third, since tBMA was commercially available, the 
synthesis of new monomers having pendant cleavable groups is not required. Fourth, in 
order to prove a facile bioconjugation of HO-ABPs with cell targeting biomolecules, 
here, terminal OH groups were conjugated with biotin (vitamin H) for the synthesis of 
biotin-terminated ABPs.  
This chapter comprises material published in Journal of Polymer Science Part A: 





Figure 3.1. Synthesis of HO-ABPs by consecutive ATRP of OEOMA and tBMA in the 
presence of a HO-terminated ATRP initiator (HO-iBuBr), as well as aqueous 
micellization and acid-triggered dissociation of HO-ABP micelles as contolled drug 
delivery nanocarriers (bpy: 2,2′-bipyridyl, PMAA: poly(methacrylic acid)).  
 
3.2.      Experimental section 
The detailed procedures of synthesis and characterization are described in 
Appendix A. 
3.3. Synthesis of HO-POEOMA-Br macroinitiator 
My experiments began with the synthesis of a hydroxyl-terminated ATRP 
initiator (HO-iBuBr) through a facile carbodiimide coupling reaction. The structure is 







 Next, a seris of ATRP of OEOMA in the presence of HO-iBuBr in acetone 
at 47 ºC was carried out under various conditions. The important parameters that 
significantly influence the kinetics and control of ATRP of OEOMA were investigated. 
Table 3.1 summarizes the results.  

















HO-MI-1 CuBr PMDETA 2.0 0.81 12,200 15,400 1.22 
 
HO-MI-2 CuCl PMDETA 2.2 0.80 12,000 15,600 1.39 
 
HO-MI-3 CuBr bpy 4.0 0.78 11,700 14,300 1.40 
 
 
a [OEOMA]0 /[HO-iBuBr]0/[catalyst]0/[Ligand]0 = 50/1/0.5/0.5 for PMDETA and 1/0.5/1 for bpy;  OEOMA/acetone = 1.5/1 v/v. 
b Determined by GPC with PMMA standards. 
c Theoretically calculated molecular weight: Mn,theo = [OEOMA]0/[HO-iBuBr]0 × MW(OEOMA) × conversion. 
 
With the target degree of polymerization (DP) defined as the initial ratio of 
[OEOMA]0/[HO-iBuBr]0 = 50, ATRP of OEOMA in the presence of 
CuBr/N,N,N′,N′′,N′′-pentamethyldiethylenetriamine (PMDETA) (HO-MI-1) and 
CuCl/PMDETA (HO-MI-2) proceeded rapidly, reaching 80% conversion in 2 hrs. This 
result suggests no significant difference in kinetics for catalysts complexed with 
PMDETA. However, CuBr/PMDETA complex gave better control with Mw/Mn < 1.22, 
compared with CuCl/PMDETA active complex in this system. Polymerization with 
CuBr/bpy (HO-MI-3) proceeded more slowly; reaching 78% conversion in 4 hrs 
(Appendix A, Figure A.1.). To synthesize well-defined HO-POEOMA-Br macroinitiators 
(HO-MI-Br) with a short chain length, the recipe HO-MI-3 was then repeated while 
polymerization time was shortened to 30 minutes. The resulting polymer was purified by 
precipitation from hexane to remove unreacted OEOMA monomers, followed by passing 
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it through a column filled with basic aluminum oxide to remove residual Cu species. The 
gel permeation chromatography (GPC) results indicate that the resulting HO-POEOMA-
Br had molecular weight, Mn = 9,500 g mol
−1
 with molecular weight distribution as 
narrow as Mw/Mn = 1.22 (Figure 3.2). 
1
H-NMR was used to determine the DP (Figure 
3.3a). A NMR signal at 1.4 ppm corresponds to two methyl protons (a) and the singlet 
appeared at 3.3 ppm corresponds to methoxy protons. From the integral ratio of peaks 
[(b/3)/(a/6)] (Figure 3.3a), the DP of HO-POEOMA-Br (HO-MI-Br) was determined to 
be 19. 
3.4. Synthesis of HO-POEOMA-b-PtBMA ABP 
 In the presence of the dried, purified HO-POEOMA19-Br MIs, ATRP of tBMA 
was conducted in acetone at 47 °C under the conditions of [tBMA]0/[HO-POEOMA-
Br]0/[CuBr]0/[bpy]0 = 200/1/0.5/1. The GPC trace evolved to a higher molecular weight 
region with Mn = 20,800 g mol
−1
 and Mw/Mn = 1.24 (Figure 3.2). From the integral ratio 
of [(c/9)/(b/3)] with the DP = 19 for HO-POEOMA-Br, the 
1
H-NMR integration was 
used to determine the DP of the PtBMA block to be 67 (Figure 3.3b). The GPC and 
1
H-
NMR results suggest the successful synthesis of well-controlled HO-POEOMA19-b-




Figure 3.2. GPC traces of HO-ABP and HO-POEOMA-Br MI. 
 
3.5. Hydrolytic cleavage of t-butyl groups in HO-ABPs 
The cleavage of pendant t-butyl groups in PtBMA blocks of HO-ABP in the 
presence of trifluoroacetic acid was examined. Figure 3.3c shows the 
1
H-NMR spectrum 
of the hydrolyzed polymers in DMSO-d6. The signal at 1.5 ppm, resulting from t-butyl 
protons completely disappeared. Further, solubility change was observed; while HO-ABP 
was dissolved in CDCl3 before hydrolysis, it had poor solubility and precipitated in 
chloroform after hydrolysis. These results suggest significant hydrolysis of t-butyl ester 
groups of PtBMA blocks to form pendant acid moieties. 
3.0 3.5 4.0 4.5 5.0 5.5
log Mn (g/mol)
HO-MI-Br
Mn = 9,500 g/mol
Mw/Mn = 1.22
HO-ABP







H-NMR spectra of HO-MI (a), HO-ABP before (b), and after (c) hydrolytic 
cleavage of PtBMA block in the presence of trifluoroacetic acid. 
 
 
3.6. Aqueous micellization of HO-ABPs 
A solvent evaporation method
[93]
 was used to form HO-ABP micelles consisting 
of a hydrophobic PtBMA core surrounded with hydrophilic POEOMA corona in aqueous 
solution. Its critical micellar concentration (CMC) was determined using a fluorescence 
spectroscopy technique with Nile Red (NR) probe. A series of mixtures consisting of a 
constant concentration of NR and various amounts of HO-ABP ranging from 10
-5
 to 0.08 
mg mL
-1
 in aqueous solution was prepared by solvent evaporation method. Figure 3.4a 
shows overlaid fluorescence spectra of NR in the solution measured at λex = 592.05 nm 
after the removal of THF by evaporation and free NR by filtration. The weak 












fluorescence intensity at lower concentrations of HO-ABP show that the NR was not 
encapsulated. However, a steady increase in fluorescence intensity was observed by 
increasing the concentration of HO-ABP, indicating the formation of micelles (Figure 
3.4b). Each dataset was fitted to linear regression. From two obtained equations, the 
CMC of HO-ABP was determined to be 6.3 μg mL-1.  
 
Figure 3.4. Evolution of fluorescence spectra (a) and fluorescence intensity at 480 nm (b) 
of NR for aqueous mixtures consisting of NR with various amounts of HO-ABP to 
determine CMC to be 6.3 μg mL-1. 
 
Due to the amphiphilic nature of HO-ABP, the purified polymer self-assembled to 
form colloidally stable micellar aggregates in aqueous solution. At the concentration of 
50 µg mL
-1
, above CMC, dynamic light scattering (DLS) results show the formation of 
micelles with a monomodal size distribution of 28.8 ± 0.1 nm in diameter. DLS data was 
collected from a single sample measured 3 times with 12 runs in each measurement. The 
average and standard deviation were calculated using the data collected from the 3 
measurements (Figure 3.5a). Further, the micelle size remained similar over micellar 
concentration ranging from 0.05 to 5 mg mL
-1
 (Figure 3.5b). The morphology of micelles 

















































was then studied using transmission electron microscopy (TEM) measurement. TEM 
microscopic image indicates the average diameter of dried micelles = 12.5 ± 2.5 nm 
(inset in Figure 3.5a).  The micelle size was smaller by TEM than by DLS; the difference 




Figure 3.5. DLS diagram and TEM image (inset) with scale bar = 100 nm (a) and 
diameter over concentration (b) of HO-ABP micelles.  
 
3.7. Destabilization of HO-ABP micellar aggregates in acidic condition 
pH-responsive degradation of HO-ABP micelle was examined by following the 
change in micelle size at different pH values using DLS. Micellar dispersion was 
prepared at the concentration of 5 mg mL
-1
. Its aliquots were adjusted to pH = 5 and 3 
using an aqueous potassium hydrogen phthalate (KHP) buffer solution at pH = 3. The 
size of micelles in the control sample at pH = 7 did not change and the dispersion 
remained transparent, as shown in Figure 3.6. After 4 days, at pH = 5, the DLS results 
indicate a slight increase in the micelle size from 28.8 to 29.7 nm, with the occurrence of 
a new population of large aggregates (> 1 µm). The micellar dispersion became cloudy, 
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suggesting the formation of large aggregates. By decreasing the pH further to 3, the 
average diameter of micelles increased more significantly from 28.8 to 34.6 nm with a 
larger population of large aggregates (Figure 3.6). DLS data was collected from a single 
sample measured 3 times with 12 runs in each measurement. The Dn was calculated using 
the data collected from the 3 measurements. Such a variation of micelle size in acidic 
environments could be due to hydrolytic cleavage of pendant t-butyl groups, resulting in 
the formation of hydrophilic PMAA blocks.  
 
Figure 3.6. DLS diagrams (a) and digital images (b) of HO-ABP micelles at pH = 7, 5, 
and 3 after 4 days. 
 
3.8. Physical encapsulation of model drug 
To examine applicability of self-assembled HO-ABP micelles as a potential drug 
delivery carrier, the encapsulation of model drugs was examined. Physical entrapment is 
a facile method to load small drugs in micelles.
[95]
 Here, the physical encapsulation of NR 
as a hydrophobic model drug was examined to investigate the effect of the weight ratio of 
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NR/HO-ABP on physical loading. Micellization of HO-ABP with NR in water through 
the solvent evaporation method yielded NR-loaded micelles. After removal of excess NR 
by centrifugation and subsequent filtration, the micelles were concentrated by rotary 
evaporation. The residues were dissolved in THF, and using the Beer-Lambert equation 





(Appendix A, Figure A.2.),
[91]
 the loading level and loading efficiency (LE) of NR in 
micelles were determined. All samples were performed in triplicate.  
As presented in Table 3.2, with the weight ratio of NR/HO-ABP = 1.0/10 at 0.5 
mg mL
−1
 concentration of HO-ABP micelles, the loading level was 0.4% with LE = 
4.1%. With a decreasing ratio of NR/HO-ABP to 0.2/10 wt/wt at higher concentration of 
HO-ABP micelles (3.3 mg mL
−1
), the loading level increased to 1.1% and LE to 55.9%. 
In addition, DLS results indicate that their hydrodynamic diameters remained similar to 
that of micelles without NR, suggesting no significant effect of the presence of NR on 
micellization of HO-ABP in aqueous solutions (Appendix A, Figure A.4.).  
Table 3.2. Encapsulation of NR in HO-ABP micelles at different weight ratios of 
NR/HO-ABP. 
HO-ABP 

























1.1 ± 0.1 55.9 ± 0.1 27.3 
a Determined by the weight ratio of NR encapsulated in micelles to dried polymers. 




3.9. Biotinconjugation with biotin and Avidin-HABA assay 
Active targeting to specific cells through bioconjugation of delivery vehicles with 
cell targeting agents is a highly desired property for polymer-based drug delivery 
nanocarriers.
[96]
 Specific targeting reduces serious side effects common to small drugs, as 
well as enhances drug efficiency. To assess the applicability of HO-ABP toward targeted 
delivery, the conjugation of HO-ABP with vitamin H (biotin) was examined. A facile 
carbodiimide coupling reaction between COOH groups of biotin and OH groups of HO-
ABP micelle was employed in the presence of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC) for 12 hrs. Unreacted biotin was removed by 
extensive dialysis against aqueous NaHCO3 solution. The purified biotin-labeled HO-
ABP (Biotin-ABP) was collected by rotary-evaporation and used to form biotinylated 
micelles at concentration of 5.0 mg mL
−1
 through solvent evaporation method (Figure 
3.7a).  
The bioavailablity of biotin present in the OH-functionalized ABP was evaluated 
by a competitive Avidin/2-(4-hydroxyphenylazo)benzoic acid (HABA) binding assay via 
UV/Vis spectroscopy.
[97]
 Avidin is a protein with four binding pockets for HABA as well 
as biotin. Since Avidin has higher binding affinity to biotin than HABA, HABA in an 
Avidin-HABA complex can be replaced by biotin. Figure 3.7b shows the UV−Vis 
spectra of Avidin-HABA complex before and after the addition of biotinylated micelles. 
Upon the addition of biotin-functionalized ABP micelles, the absorbance at 500 nm 
decreased by ΔA = 0.79; this specifies Avidin–biotin complexation. Using a calibration 
curve reported elsewhere,
[98]
 the difference of absorbance allows for the calculated 




Figure 3.7. Schematic illustration of bioconjugation of HO-ABP with biotin to form 
biotin-conjugated ABP (a) and UV–Vis spectra of Avidin–HABA complex before and 
after addition of biotinylated micelles in aqueous solution (b). 
 
3.10. Noncytotoxicity of HO-ABP micelles  
A MTT assay was used to assess the cytotoxicity of HO-ABP micelles. Different 
cell lines including human embryonic kidney (HEK293T) and HeLa cancer cell lines 
were examined. Both cell lines were incubated with different concentrations of HO-ABP 
micelles for 48 hrs. Figure 3.8 shows > 95% viability of cells, suggesting the nontoxicity 










Well-defined HO-ABP block copolymers were synthesized by consecutive ATRP 
of OEOMA and tBMA in the presence of a HO-iBuBr initiator in acetone. The obtained 
polymers were characterized by 
1
H-NMR and GPC measurements. Due to the 
amphiphilic nature, HO-ABPs self-assembled, through aqueous micellization to form 
spherical micellar aggregates with a diameter = 28.8 nm as determined by DLS and 12.5 
nm when measured by TEM. The CMC was found to be 6.3 μg mL−1 using a NR 
fluorescence probe method. The hydrophobic core of micelles enabled the encapsulation 
of hydrophobic model drugs. The hydrolysis of pendant t-butyl groups of PtBMA in 
acidic condition resulted in doubly hydrophilic HO-POEOMA-b-PMAA block 
copolymers. In acidic pH, HO-ABP micelles were destabilized to form large aggregates. 
As proof of concept, the biotinylated micelles were prepared. The Avidin-HABA assay 
results indicate that the availability of biotin was 0.93 biotin per HO-ABP chain. These 
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results, combined with noncytotoxicity, suggest that new HO-terminated ABP micelles 








      Thiol-Responsive Mono-Cleavable Micelles 
 
4.1.  Introduction 
A strategy toward the development of reduction-sensitive degradable micelles 
involves the introduction of disulfide linkages into well-defined ABPs.
[55]
 Different 
number of disulfide linkages are positioned at various locations; such as in main chains, 
at side chains, or the cross-links.
[17, 99]
 For reductively degradable micelles having 
disulfides in main chains, backbone multi-cleavable micelles
[21, 62, 100]
 and sheddable 
micelles
[101]
 have been reported. Their characteristics are described in Section 1.5 in 
Chapter 1. Mono-cleavable micelles are new and based on symmetric triblock copolymer 
having single disulfides in the middle blocks. After our publication,
[102]
 several examples 
of mono-cleavable micelles have been reported. They include multi-armed poly(ε-
caprolactone)-b-poly(ethylene oxide) copolymers,
[103]
 comb-like alternating copolymers 
consisting of styrenic and N-(2-hydroxyethyl) maleimide units
[40]




This chapter describes the first example of mono-cleavable micelles based on 
novel comb-type triblock copolymers consisting of hydrophilic POEOMA and 
hydrophobic poly(oligo(propylene oxide) monononylphenyl ether acrylate (PAP) blocks. 
As illustrated in Figure 4.1, single disulfide linkages are positioned in the center of the 
triblock copolymers; thus named POEOMA-b-PAP-ss-PAP-b-POEOMA (ss-ABP2). 
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These block copolymers were synthesized by a consecutive ATRP of oligo(propylene 
oxide) monononylphenyl ether acrylate (AP) in the presence of a difunctional Br-initiator 
labeled with a disulfide linkage (SS-DBr) and then OEOMA. The resulting ss-ABP2 self-
assembled to form colloidally stable micellar aggregates in aqueous solutions at 
concentration above the CMC. Their thiol-responsive degradation by cleavage of 
disulfide linkages in their micelle cores led to a change in morphology to smaller 
aggregate structures, as confirmed by dynamic light scattering (DLS) and atomic force 
microscopy (AFM) measurements.  
This chapter comprises material published in Macromolecular Rapid 








Figure 4.1. Illustration of synthesis, aqueous micellization, and degradation of mono-
cleavable brush-like ss-ABP2 triblock copolymers labeled with single disulfides in the 
middle blocks (PMDETA : N,N,N′,N′′,N′′-pentamethyldiethylenetriamine, Bu3P: 
tributylphosphine ). 
 
4.2. Experimental section 
The detailed procedures of synthesis and characterization are described in 
Appendix B. 
4.3. Synthesis of ss-(PAP-Br)2 macroinitiator (MI) 
Bis[2-(2-bromoisobutyryloxy)ethyl] disulfide (SS-DBr) difunctional ATRP 
initiator was synthesized by A. Nelson-Mendez in our group using a carbodiimide 
coupling reaction (
1
H-NMR spectra of SS-DBr before and after purification is given in 





 In the presence of SS-DBr initiator, a series of ATRP of AP was 
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conducted in acetone under various conditions. An Activators Generated by Electron 
Transfer (AGET)
[71]
 process for ATRP was examined here. With the initial mole ratio of 
[AP]0/[SS-DBr]0 = 50/0.5, important parameters including temperature and [CuBr2]0/[SS-
DBr]0 were varied to synthesize well-controlled ss-(PAP-Br)2 MI’s. Table 4.1 summarizes 
the results.  




































1 0.5/1 60 15.0 0.16 6,700 7,300 1.22 
2 0.5/1 80 8 0.36 15,000 11,700 1.51 
3 1/1 80 21.0 0.24 10,000 12,000 1.22 
 
a [AP]0/[SS-DBr]0 = 50/0.5, [CuBr2]0/[Sn(Oct)2]0 = 1/1.3, AP/acetone = 1.5/1 v/v. 
b Determined by GPC with PMMA standards. 
c Theoretically calculated molecular weight: Mn,theo = [AP]0/[SS-DBr]0 × MW(AP) × conversion. 
 
For AGET ATRP with [CuBr2]0/[SS-DBr]0  = 0.5/1 at 60 ºC, conversion reached 
16% in 15 hrs, suggesting slow polymerization (ss-(PAP-Br)2-1). The resulting polymer 
had number average molecular weight Mn = 7,300 g mol
-1
 with a molecular weight 
distribution as narrow as Mw/Mn = 1.22. When the polymerization temperature was 
increased from 60 to 80 ºC, conversion increased to 36% in 8 hrs, but the polydispersity 
index (PDI) also increased to 1.51 (ss-(PAP-Br)2-2), indicating a loss of control during 
the polymerization. The amount of deactivators of CuBr2 complex as the ratio of 
[CuBr2]0/[SS-DBr]0 was then increased at the same temperature of 80 ºC (ss-(PAP-Br)2-
3) to enhance the rate of deactivation. With a higher concentration of copper species, 
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= 1.22. After purification by removal of unreacted PA 
monomers and Cu species, the purified (ss-(PAP-Br)2-3) had the degree of 
polymerization (DP) = 24, calculated from monomer conversion; thus Br-12PAP-ss-
PAP12-Br (ss-(PAP12-Br)2).  
Kinetics of AGET ATRP AP was further examined. Figure 4.2 shows the results. 
For both ss-(PAP-Br)2-1 and ss-(PAP-Br)2-3, polymerization proceeded at a steady rate 
for the first 4 hours. However, the polymerizations slowed significantly for both reactions 
after the initial burst, possibly due to oxidation of copper(I) activators to copper(II) 
deactivators as oxygen was introduced during the course of polymerization.   As expected 
in a living polymerization, molecular weight increased linearly with conversion and 
molecular weight distributions remained low with Mw/Mn < 1.23. These results suggest 
successful synthesis of well-defined ss-(PAP-Br)2 MIs having single disulfide linkages 
positioned in the middle. 
 
Figure 4.2. Kinetic plot (a) and evolution of molecular weight and molecular weight 
distribution of ss-(PAP-Br)2-1 and ss-(PAP-Br)2-3 (b). The straight line in (b) is the 





4.4. Synthesis of ss-ABP2 triblock copolymer 
For the synthesis of well-defined mono-cleavable ss-ABP2, AGET ATRP of 
OEOMA was conducted for chain extension of ss-(PAP-Br)2 with water-soluble 
POEOMA. To ensure faster initiation than propagation in block copolymerization 
consisting of polyacrylate-Br MIs and methacrylates, a halogen exchange is required to 
slow down the polymerization of methacrylates. Otherwise, final block copolymers will 
be contaminated with the presence of unactivated polyacrylate MIs.
[106]
 Here, 
CuCl2/PMDETA complex was used to enable better control of ATRP of OEOMA in the 
presence of ss-(PAP-Br)2 MIs. The conditions include [OEOMA]0/[ss-(PAP-
Br)2]0/[CuCl2/PMDETA]0/[Sn(Oct)2]0 = 50/0.5/1/1.3 and OEOMA/anisole = 1.5 v/v at 80 
°C. After 2 hrs, GPC traces evolved into a higher molecular weight region with Mn = 
15,200 g mol
−1
 and Mw/Mn = 1.23 at 10% conversion (Figure 4.3a). 
1
H-NMR was used to 
compare ss-ABP2 with ss-(PAP-Br)2 (Figure 4.3b). These results suggest the synthesis of 
well-defined ss-(PAP12-b-POEOMA5-Cl)2 symmetric triblock copolymers using the 





Figure 4.3. GPC traces (a) and 
1
H-NMR spectra in CDCl3 (b) of ss-(PAP-Br)2 and ss-
ABP2. 
 
4.5. Aqueous micellization of ss-ABP2 
Owing to its amphiphilic nature, the purified ss-ABP2 formed micellar aggregates 
consisting of a hydrophobic ss-(PAP-Br)2 core surrounded with short hydrophilic 
POEOMA coronas. Critical micellar concentration (CMC) was determined using 
tensiometry. An aqueous stock solution of ss-ABP2 at a concentration of 1.0 mg mL
−1
 was 
prepared by solvent evaporation method. Aliquots of the stock solution were diluted with 
various amounts of water. The surface pressure was recorded at different concentrations 
ranging from 2.8 to 90 µg mL
−1
. As seen in Figure 4.4, at lower concentrations the 
pressure of aqueous solutions was as low as < 1 mN  m−1. When the concentration 
increased, the pressure rapidly increased, and then became constant. Each dataset was 
fitted to linear regression. From two obtained equations, the CMC of ss-ABP2 was 
determined to be 32 µg  mL−1.  








Mn = 15,200 g/mol
Mw/Mn = 1.23













Figure 4.4. Surface pressure versus concentration of ss-ABP2 to determine CMC by 
tensiometry. 
 
4.6. Reductive cleavage of disulfide linkages in ss-ABP2 
Reductive cleavage of single disulfide linkages in the middle blocks of ss-ABP2 
triblock copolymers was examined. When all disulfide linkages of ss-ABP2 are cleaved 
by reductive reactions under reducing conditions, the degraded products could be thiol-
terminated diblock copolymers (HS-PAP-b-POEOMA) with a half molecular weight of 
ss-(PAP-b-POEOMA)2. For GPC measurements, ss-ABP2 was dissolved in THF and 
mixed with tributylphosphine (Bu3P) at a mole equivalent ratio of Bu3P/disulfide = 1/1 
for 24 hrs. As seen in Figure 4.5, molecular weight of ss-ABP2 decreased from Mn = 
14,500 g mol
−1
 to Mn = 5,500 g  mol
−1
. This result indicates the significant cleavage of 
disulfide linkages in ss-ABP2 under reducing conditions. 



























Figure 4.5. GPC traces of ss-ABP2 before and after reductive cleavage of disulfide 
linkages in the presence of Bu3P. 
 
4.7. Reductively-degradable ss-ABP2 micellar aggregates  
Thiol-responsive degradation of self-assembled micelles through disulfide-thiol 
exchange in the presence of DL-dithiothreitol (DTT) was examined using AFM and DLS. 
Micellar dispersion was prepared at the concentration of 1.0 mg mL
-1
. Aliquots of 
micellar dispersion were mixed with DTT as the mole equivalent ratio of DTT/disulfide 
= 1/1. As seen in Figure 4.6, the color of the mixtures changed from turbid to lightly 
blue-tint over 24 hrs. DLS results indicate that particle diameter was ≈ 109 nm in the 
absence of DTT (Figure 4.6a), and then decreased to 70.4 nm when DTT was added 
(Figure 4.6b). DLS data were collected from a single sample measured 3 times with 60 
runs in each measurement; the particle diameter were calculated using the data collected 
from the 3 measurements. Further, the change of morphology in response to reductive 
reactions with DTT in water was explored using AFM. The dispersion without and with 
3.0 3.5 4.0 4.5 5.0
log Mn (g/mol)
Cleaved ss-ABP2
Mn = 5,500 g/mol
Mw / Mn = 1.31
ss-ABP2
Mn = 14,500 g/mol
Mw / Mn =  1.23
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DTT/ disulfide = 1/1 were spin-cast on mica surface. The AFM measurements were done 
by Dr. R. Schmidt in the Centre for NanoScience Research at Concordia University. 
AFM image of the micelles without DTT shows the presence of large particles along with 
small particles (Figure 4.6c). The average diameter was calculated to be 
255.5 ± 128.7 nm, which is larger than particle size determined by DLS. The difference is 
attributed to flattening of the particles on the mica during the casting process. In the 
presence of DTT, the AFM image of micelles shows fairly uniform distribution of small 
particles with the average diameter = 97.8 ± 21.8 nm (Figure 4.6d). These results suggest 
the cleavage of disulfides in the micellar cores to the corresponding thiol-terminated 
degraded products in presence of DTT. These degraded polymers are still amphiphilic, 






Figure 4.6. For ss-ABP2 symmetric triblock copolymers, DLS diagrams based on % 
volume and AFM images with the size = 10 µm × 10 µm before (a and b) and after (c and 
d) addition of DTT defined as DTT/disulfide = 1/1 in water (insets; digital images of 
micellar dispersions in water). 
 
4.8. Conclusions 
New thiol-responsive symmetric triblock copolymer having single disulfide 
linkages in the middle blocks were synthesized using AGET ATRP. These mono-
cleavable copolymers consist of hydrophobic PAP and hydrophilic POEOMA. 
Polymerizations were well-controlled, yielding both ss-(PAP-Br)2 and ss-ABP2 with 
monomodal and narrow molecular weight distributions with PDI as low as Mw/Mn < 
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1.23.  Due to the amphiphilic nature, ss-ABP2 self-assembled, through aqueous 
micellization, to form micellar aggregates at concentrations above CMC. For reductive 
cleavage of single disulfides in the mono-cleavable copolymers and micelles, GPC results 
suggest that copolymers in the presence of Bu3P were cleaved to corresponding HS-
terminated PAP1/2-b-POEOMA with a half molecular weight. The AFM and DLS 
analyses suggest the degradation of ss-ABP2 micelles to small amphiphilic thiols, leading 







      Glutathione-Responsive Micelles Having 
Pendant Disulfide Linkages 
 
5.1.  Introduction 
Pendant multi-cleavable micelles are a promising class of drug delivery 
nanocarriers.   These micelles are based on well-defined ABPs having pendant disulfide 
linkages as side chains. Of the strategies for the synthesis of thiol-responsive degradable 
nanosized assemblies, as reviewed in chapter 1 (Figure 1.7), amphiphilic block 
copolymer containing pendant disulfides in hydrophobic cores can be cleaved in response 
to excess reducing agents, causing the destabilization of micellar aggregates through the 
change in hydrophobic/hydrophilic balance.
[107]
 Alternatively, these micelles are 
converted to core-crosslinked micelles with disulfide crosslinks through intermolecular 
thiol-disulfide polyexchange reactions in the presence of catalytic amount of reducing 
agents. This feature can enhance colloidal stability upon dilution below CMC, thus 
preventing premature release of encapsulated drugs during circulation in the body.  
Several examples of reduction-sensitive core-crosslinked nanogels or micelles 
have been reported. Random copolymers prepared from dextran-lipoic acid derivatives 
(Dex-LAs)
[108]
 and poly(ethyleneglycol) (PEG) and poly(ɛ-caprolactone) (PCL) were 
used to prepare crosslinked nanogels that contained two lipoyl functional groups at their 
interfaces.
[109]
 Redox-responsive micelles composed of various ABPs with pendant multi-
 61 
 
cleavable functionalities have also been reported.  ABPs consisting of poly(N-(2-
hydroxypropyl)methacrylamide) (PHPMA) and poly(2-(pyridyldisulfide)ethyl 
methacrylate),
[110]
  and well-defined ABPs consisting of PEG and L-lactide(LA)-co-2-
(2,4-dinitrophenylthio)ethyl-5-methyl-2-oxo-1,3-dioxane-5-carboxylate (MTC) (mPEG-
b-P(LA-co-MTC)) have been studied.
[111]
 Another example includes well-controlled 
core-crosslinked PEG-b-PHPMA-lipoic acid conjugates (PEG-b-PHPMA-LA) micelles 
prepared by reversible addition fragmentation chain transfer (RAFT) polymerization.
[112]
 
Also recently cross-linked polyester micelles based on monomethoxy poly(ethylene 




Recently, our research group has reported the synthesis of new ABPs having 
pendant disulfides positioned at the hydrophobic block as illustrated in Figure 5.1.
[64]
 
These ABPs consist of hydrophilic poly(ethylene oxide) (PEO) and hydrophobic pendant 
disulfide-labeled polymethacrylate (PHMssEt) blocks. They were synthesized by atom 
transfer radical polymerization (ATRP) of a novel pendant disulfide-functionalized 
methacrylate (HMssEt) in the presence of PEO-Br macroinitiator. The self-assembled 
micellar nanostructures of well-defined PEO-b-PHMssEt exhibited tunable release of 
encapsulated model drugs such as Nile Red in aqueous solution with morphology 







Figure 5.1. Preparation of well-controlled PEO-b-PHMssEt via ATRP (PMDETA: 
N,N,N′,N′,N′′-pentamethyldiethylenetriamine). 
 
This chapter describes the results obtained from my in-depth evaluation of thiol-
responsive degradable PEO-b-PHMssEt micelles as effective intracellular delivery 
nanocarriers of anticancer drugs. In response to cellular GSH, the destabilization of these 
micelles upon cleavage of pendant disulfide linkages was monitored by dynamic light 
scattering (DLS) technique. This micellar destabilization led to enhanced release of 
encapsulated doxorubicin (DOX) as a model anticancer drug. Further, GSH-responsive 
degradation of DOX-loaded micelles was investigated in cellular environments using 
flow cytometry and confocal laser scanning microscopy (CLSM) for cellular uptake 
(Figure 5.2). 
This chapter comprises material published in Biomacromolecules, 2013, 14, 2103-











Figure 5.2. Illustration of PEO-b-PHMssEt micelles as effective intracellular drug 
delivery nanocarriers exhibiting enhanced release of DOX in response to GSH in cancer 
cells. 
 
5.2. Experimental section 
The detailed procedures of synthesis and characterization are described in 
Appendix C. 
5.3. Synthesis and aqueous micellization of PEO-b-PHMssEt 
Well-defined PEO-b-PHMssEt was previously synthesized by Dr. Q. Zhang in 
our group.
[64]
 The polymer was characterized by GPC, and found to have Mn = 25,400 g 
mol
-1
 and Mw/Mn = 1.11, along with DP = 42 as determined by 
1
H-NMR; thus PEO113-b-
PHMssEt42 having 42 pendant disulfide linkages per each polymer chain.  
The resulting PEO-b-PHMssEt is amphiphilic and self-assembled to form 
micellar aggregates in aqueous solution. Its critical micellar concentration (CMC) was 
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determined to be 49 μg mL-1 using tensiometry, has been reported in our previous 
publication.
[64]
 Here, aqueous micellization of PEO-b-PHMssEt in dimethylformamide 
(DMF) through a dialysis method was examined to prepare micellar aggregates at 0.9 mg 
mL
-1
 concentration. As seen in Figure 5.3, DLS results indicate their number average 
diameter (Dn) to be 145.2 ± 0.7 nm with relatively narrow size distribution 
(polydispersity, Dw/Dn < 1.13). DLS data was collected from a single sample measured 3 
times with 12 runs in each measurement. The average and standard deviation were 
calculated using the data collected from the 3 measurements (Figure 5.3). The above 
results suggest that PEO-b-PHMssEt can form spherical micelles with suitable size for 
drug delivery (< 200 nm).  
 
Figure 5.3. DLS diagram of PEO-b-PHMssEt micelles prepared using dialysis method in 
water.  
 
5.4. Redox-trigger destabilization of PEO-b-PHMssEt micellar Aggregates 
The resulting micellar aggregates of PEO-b-PHMssEt contain 42 pendant 
disulfide linkages in hydrophobic cores. The reductive cleavage of PEO-b-PHMssEt 































micelle thus results in a change of hydrophobic/hydrophilic balance, leading to the 
destabilization of micelles. To study the response of PHMssEt blocks in micellar cores to 
reductive environment, micelles were treated with a 10 mM aqueous glutathione (GSH) 
solution. DLS was used to monitor the change in size distribution of aqueous micellar 
aggregates in the absence and presence of GSH at different time intervals (Figure 5.4). 
As a control experiment, no significant change in size distribution was observed 
in the absence of GSH over 20 hrs. In the presence of 10 mM GSH, the average diameter 
of micelles increased from 145 nm to several hundred nanometers (diameter > 1 µm) 
with a broad and bimodal particle size distribution in 2 hrs. Further, the distribution 
became broader as the population of the large aggregates increased over 20 hrs 
(Appendix C, Figure C.1.). Such variations in micelle size suggest that micellar 





Figure 5.4. Evolution of DLS diagrams (volume %) of PEO-b-PHMssEt micellar 
aggregates in aqueous buffer solution as control and in 10 mM aqueous GSH buffer 
solution over time.  
 
5.5. Preparation of DOX-loaded micelles  
Doxorubicin (DOX) is one of the most potent anticancer therapeutics, which is 
widely used to treat various solid tumors. DOX can inhibit proliferation of cancerous 
cells by interacting with DNA, causing intercalation and inhibition of macromolecular 
biosynthesis.
[114]
 Here, DOX was encapsulated in hydrophobic micellar cores using the 
dialysis method. A mixture of DOX and PEO-b-PHMssEt was dissolved in DMF and 
added into water. Free DOX and DMF were then removed by intensive dialysis using a 
dialysis tubing (MWCO = 12,000 g mol
-1
) over 5 days (Appendix C, Figure C.2.). The 
removal of free DOX was monitored by measuring the absorbance of DOX at 497 nm in 
the outer dialysis water.  












The size and morphology of aqueous DOX-loaded micellar aggregates were 
examined using DLS and TEM at a micellar concentration of 2.5 mg/mL. DLS results 
suggest the presence of two populations with z-average diameter based on light scattering 
intensity to be 174 ± 16 nm. The main population (> 95% by volume) consists of smaller-
sized aggregates with Dn = 190 ± 31 nm and relatively broad size distribution (Dw/Dn > 
1.33), while a smaller population (< 5% volume) is composed of larger-sized aggregates 
with the diameter > 1 µm. DLS data was collected from multiple samples (6 samples) 
each measured 3 times with 12 runs in each measurement. Average and standard 
deviation were calculated using the collective data of each sample from each 
measurement (Figure 5.5a). TEM images also indicate a broad distribution of spherical 
micelles with average diameter = 81.3 ± 25.9 nm (Figure 5.5b). The micelle size obtained 
by TEM was smaller than found using DLS. The difference is attributed to the 




Figure 5.5. DLS diagram (a) and TEM images (b) of DOX-loaded micelles of PEO-b-
PHMssEt at 2.5 mg/mL concentration prepared by dialysis method (inset of (a): digital 
picture of DOX-loaded micellar dispersion).  
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The loading level of DOX for DOX-loaded micelles was determined using 
UV/Vis spectroscopy. The extinction coefficient of DOX in DMF was first determined to 
be ε = 11,700 M−1 cm−1 at λmax = 480 nm (Appendix C, Figure C.3.). Next, aliquots of 
DOX-loaded micellar dispersions were taken and water was removed by rotary 
evaporation. The residues were then dissolved in DMF to form clear solutions of DOX 
and PEO-b-PHMssEt. Figure 5.6 is an example of UV/Vis spectrum of DOX-loaded 
micelles in DMF which showed a strong absorption of DOX at λmax = 480 nm. The 
spectrum is similar to that of free DOX in DMF, suggesting no signification change in the 
structure of DOX encapsulated in hydrophobic micellar cores. Using the Beer-Lambert 
equation with the absorbance at λmax = 480 nm and the extinction coefficient, the loading 
level of DOX was determined to be 0.44 ± 0.07% for MDOX-1 and 0.81 ± 0.07% for 
MDOX-2 (Table 5.1). Similarly, the DOX loading level increased when the feed ratio of 
the initial amount of DOX to copolymer was increased. 
 
Figure 5.6. A typical UV/Vis spectrum of DOX-loaded micelles after the removal of 
water, compared with that of free DOX (19.5 µmol mL
-1
) in DMF.  


























Table 5.1. Loading level of DOX for DOX-loaded PEO-b-PHMssEt micelles prepared 
















MDOX-1 1/20 5/20 2.8 0.44 ± 0.07 
MDOX-2 2/20 10/20 1.7 0.81 ± 0.07 
 
5.6. GSH-triggered release of DOX from DOX-loaded micelles  
To examine GSH-responsive release of DOX from DOX-loaded micelles in the 
presence of GSH, an aliquot of DOX-loaded micellar dispersion was dialyzed against 10 
mM aqueous GSH solution buffered with KH2PO4 at pH = 7. A control experiment 
without GSH was also conducted. Figure 5.7 shows % DOX released from DOX-loaded 
micelles in the absence and presence of 10 mM GSH. In the absence of GSH, no 
significant change in UV absorbance was observed, suggesting no significant release of 
DOX; because DOX is presumably confined in small micellar cores. In the presence of 
10 mM GSH, the UV absorbance gradually increased over time and > 70 % DOX was 
released from the micelles within 4 hrs. This result suggests DOX-loaded micelles 
degrade to the corresponding water-soluble PEO-b-PHMSH, causing the enhanced 




Figure 5.7. Release of DOX from DOX-loaded micelles in 10 mM aqueous GSH 
solution buffered with KH2PO4 at pH = 7.0, and aqueous KH2PO4 buffer solution at pH = 
7.0 as a control. 
 
5.7. GSH-responsive intracellular release of DOX upon degradation  
To evaluate the efficiency of PEO-b-PHMssEt micelles as drug delivery 
nanocarriers at a cellular level, intracellular release of DOX in response to cellular GSH 
for HeLa cancer cells after internalization was investigated using flow cytometry and 
confocal laser scanning microscopy (CLSM). Figure 5.8 shows flow cytometric 
histograms of HeLa cells. Compared to cells only as a control, the histograms for HeLa 
cells incubated with DOX-loaded micelles were shifted to the direction of high 
fluorescence intensity, suggesting effective internalization of DOX-loaded micelles in 
HeLa cells in 2 hrs.  

























Figure 5.8. Flow cytometric histograms of HeLa cells incubated with DOX-loaded PEO-
b-PHMssEt micelles for 2 hrs. 
 
Intracellular release of DOX was further investigated using CLSM (Figure 5.9). 
Hela cells were incubated with DOX-loaded micelles for 24 hrs. HeLa nuclei were then 
stained with DAPI. The image from DOX fluorescence suggests that DOX-loaded 
micelles were internalized and DOX was released to reach the cell nuclei. This 





Figure 5.9. CLSM images of HeLa cells incubated with DOX-loaded PEO-b-PHMssEt 
micelles for 24 hrs. The images from left to right show cell nuclei stained by DAPI 
(blue), DOX fluorescence in cells (red), overlays of two images, and differential 
interference contrast (DIC) image. Scale bar = 20 µm.  
 
5.8. In vitro cytotoxicity of DOX-loaded micelles 
The efficiency of inhibition of cell proliferation of DOX-loaded micelles against 
tumor cells was evaluated. MTT colorimetric assay was used to evaluate the cytotoxicity 
of DOX-free (or blank) and DOX-loaded PEO-b-PHMssEt based micelles against HeLa 
cells. First, blank PEO-b-PHMssEt micelles exhibited > 80% viability of HeLa cells after 
48 hrs incubation with micelles, suggesting non-toxicity of PEO-b-PHMssEt micelles to 
cells up to 510 μg mL-1. Next, the cytotoxicity of DOX-loaded micelles upon their GSH-
responsive degradation was examined. Here, HeLa cells were incubated with various 
amounts of DOX-loaded micelles for 48 hrs. For comparison, cells were also incubated 
with free DOX. As seen in Figure 5.10, the viability decreased with an increasing amount 
of both free and encapsulated DOX, suggesting inhibition of cell proliferation in the 
presence of DOX. The viability in the presence of DOX-loaded micelles was lower, 
compared to blank micelles; this could be due to the presence of GSH found in HeLa 
cancer cells that can trigger the degradation of DOX-loaded micelles. This result suggests 
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the release of DOX from DOX-loaded micelles triggered by intracellular GSH, thus 
enhancing the inhibition of the cellular proliferation after internalization. 
 
Figure 5.10. Viability of HeLa cells incubated with different amounts of empty micelles, 
DOX-loaded micelles, and free DOX for 48 hrs. Data are presented as average ± standard 
deviation (n = 12). 
 
5.9. Conclusions 
New redox-responsive PEO-b-PHMssEt ABPs having pendant disulfide linkages 
were synthesized and self-assembled to form micellar aggregates in aqueous solution at 
concentration of above CMC of 49 µg mL
-1
. These micelles consist of hydrophobic 
PHMssEt core surrounded with hydrophilic PEO coronas. In the presence of cellular 
GSH, pendant disulfide linkages in micellar cores were rapidly cleaved, causing the 
destabilization of micelles, confirmed by DLS and UV/Vis spectroscopy measurements. 
The results of flow cytometry, CLSM and cell viability demonstrated intracellular release 
of anticancer drugs to inhibit the cellular proliferation after internalization into HeLa 




























cells. These results suggest that GSH-responsive PEO-b-PHMssEt micelles hold great 
promise as intracellular nanocarriers exhibiting the enhanced release of encapsulated 








 Conclusion and Future Works 
 
Stimuli-responsive degradable block copolymer micelles are able to provide 
significant advantages for multifunctional drug delivery. These advantageous include 
enhanced release of encapsulated biomolecules as well as changes in morphologies of 
micellar nanocarriers. Advanced techniques such as control radical polymerization (CRP) 
allow for the synthesis of ABPs with chemical flexibility which may be engineered to 
incorporate stimuli-responsive degradable moieties. Examples of degradable linkages 
include acid-labile and disulfides bonds. These degradable covalent linkages make 
nanocarriers capable of undergoing changes in one or more physical properties in 
response to external triggers; thereby, triggering the programmed release of encapsulated 
biomolecules, particularly anticancer therapeutics. The objective of my master research 
was to explore stimuli-responsive degradation by designing new types of amphiphilic 
block copolymers. The obtained results contributed to a better understanding of the 
structure-property relationship between morphological variance and stimuli-responsive 
degradation. In this thesis, three different types of stimuli-responsive degradable micelles 
were developed exhibiting pH or thiol-responsive degradation through atom transfer 
radical polymerization (ATRP).  
First, well-defined OH-terminated HO-POEOMA-b-PtBMA block copolymers 
were synthesized by consecutive ATRP of oligo(ethylene oxide) monomethyl ether 
methacrylate (OEOMA) and t-butyl methacrylate (tBMA) in the presence of a HO-
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terminated alkyl halide initiator. 
1
H-NMR and GPC results suggest that polymerizations 
preceded in a living fashion, yielding both HO-MI and HO-ABP with monomodal and 
narrow molecular weight distributions as low as Mw/Mn < 1.25. Self-assembly of these 
ABPs was first studied in aqueous solution using DLS and TEM. The encapsulation of 
small molecules within the hydrophobic micellar core of these micelles was investigated 
by loading the micelles with Nile Red (NR), and up to 1.1 wt% loading within micelles 
was observed. Hydrolytic cleavage of t-butyl group of PtBMA resulted in doubly 
hydrophilic HO-POEOMA-b-PMAA block copolymers. In acidic pH, HO-ABP micelles 
were gradually destabilized to form large aggregates. To demonstrate bioconjugation, the 
terminal OH groups were functionalized with biotin through a facile carbodiimide 
coupling reaction. These preliminary studies were encouraging, however, more work is 
required in order to increase HO-ABPs’ sensitivity to acidic environment. In addition, by 
varying the nature of the pendant group, micelle destabilization kinetics can be tuned to 
occur at a more rapid rate and at a pH more representative of a cancer tissue's 
environment. 
As detailed in chapter 4, a novel type of amphiphilic mono-cleavable triblock 
copolymer having single disulfide linkages in the hydrophobic main chains was 
synthesized and utilized to study redox-responsiveness of micelle in the presence of 
reducing agents. The mono-cleavable copolymer consisted of hydrophobic 
poly(oligo(propylene oxide) monononylphenyl ether acrylate (PAP) and hydrophilic 
POEOMA, thus attaining amphiphilicity and having a bush-like structure. Consecutive 
(activator generated by electron transfer) AGET ATRP of OEOMA in the presence of ss-
(PAP-Br)2 macroinitiators yielded well-defined ss-ABP2 triblock copolymers, as 
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confirmed by GPC and 
1
H-NMR. Formation of micellar aggregates in aqueous solution 
was studied by tensiometry and DLS. Their thiol-responsive degradation by cleavage of 
disulfide linkages in their micelle cores led to the change in morphologies to smaller 
aggregate structures, which was confirmed by DLS and AFM measurements. As the 
results presented in chapter 4 were merely preliminary, more work still needs to be done 
on the current system in order to utilize its potential as controlled delivery vehicles. 
Another class of thiol-responsive degradable micelles, which consisted of block 
copolymers with disulfide linkages in side chains (pendant multi-cleavable micelles), was 
presented in chapter 5. Well-controlled PEO-b-PHMssEt ABPs was previously 
synthesized in our group. Self-assembly of PEO-b-PHMssEt to form micellar aggregates 
in aqueous solution was confirmed by DLS. Further investigation by TEM revealed the 
formation of spherical micelles. The encapsulation of anticancer drug within the 
hydrophobic micellar core of micelles was investigated by loading the micelles with 
doxorubicin, and up to 0.8% loading within the micelles was observed. The loading level 
is a modest, yet encouraging level of encapsulation. The micelles were designed to 
exhibit reduction-responsive degradation properties; consequently, pendant disulfide 
linkages in micellar cores were cleaved in the presence of GSH, resulting in degradation 
or destabilization of micellar nanocarriers. Such degradation led to the enhanced release 
of encapsulated anticancer drugs in aqueous solutions, which was monitored by DLS and 
UV absorbance measurements. In vitro release of doxorubicin to HeLa cellular 
environments was also performed. The efficiency of therapeutic release, was analyzed 
using MTT-based cell viability measurements. Intracellular release of anticancer drugs 
after internalization into HeLa cancer cells was evidenced by flow cytometry and CLSM. 
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Although these results suggest that PEO-b-PHMssEt micelles hold great promise as 
intracellular nanocarriers, more work needs to be done in order to develop the the 
medicinal value of these GSH-responsive micelles. Therefore, PEO-b-PHMssEt structure 
may be tailored and better-optimized to suit its desired application. Additionally, one 
possibility would be to conjugate drugs through a cleavable site to the hydrophobic core. 
This would enhance drug loading efficiency and prevent premature drug release.  
Future work with these stimuli-responsive degradable micelles also should 
involve the testing of their stability over time in biological conditions. The ability of the 
proposed nanosized polymeric micelles to accumulate in tumor cells primilarily relied 
upon the enhanced permeability and retention (EPR) effect for passive targeting of 
tumors. By introducing active targeting moieties, particularly through the attachment of a 
cancer cell selective targeting moiety to their surface, the activity of these nanoparticles 
could be further enhanced. The epidermal growth factor receptor (EGFR) is one target 
that is commonly used for active targeting. EGa1 is a small antibody with specific 
binding to the EGFR receptor.
[115]
 Hence, it would be encouraging to see the 
development of PEO-b-PHMssEt functionalized with EGa1 in order to improve their 
therapeutic efficacy. Also, it would be extremely beneficial to develop multifunctional 
amphiphilic block copolymers for many purposes such as drug delivery and diagnostics 
with the ability to respond to several stimuli. Such a system could find far-reaching 
applications in medicine by taking advantage of the unique properties of these polymers. 
Regardless of the many advances, many challenges and opportunities remain for making 
an impact in the field of smart polymers. While new stimuli-responsive degradable 
polymeric micelles are continually being developed and the ability to prepare complex 
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macromolecules architectures is growing, many underused stimuli will take on greater 







      Experimental Section of Chapter 3 
 
A.1. Materials  
Ethylene glycol (EG), 2-bromoisobutyric acid (Br-iBuA), N,N´-dicyclohexyl 
carbodiimide (DCC), N,N-dimethylaminopyridine (DMAP), N-(3-
dimethylaminopropyl)-N´-ethylcarbodiimide hydrochloride (EDC), N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDETA, >98%), 2,2′-bipyridyl (bpy), copper(I) 
bromide (CuBr, >99.99%), copper(I) chloride (CuCl, >99.99%), trifluoroacetic acid 
(CF3COOH), avidin from egg white, biotin (>99%, lyophilized powder), 2-(4-
hydroxyphenylazo)-benzoic acid (HABA), and potassium hydrogen phthalate (KHP) 
were used as received from Aldrich. For cell viability assay, Dulbecco’s modified eagle 
medium (DMEM, 100 µL) and fetal bovine serum (FBS) were used as received from 
Wisent and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, a 
yellow tetrazole) was used as received from Promega. OEOMA with MW = 300 g mol
-1
 
and pendant ethylene oxide (EO) units ≈ 5 and tBMA from Aldrich were purified by 
passing it through a column filled with basic alumina to remove inhibitors. 
A.2. Synthesis and purification of 2-hydroxyethyl-2´-bromoisobutyrate (OH-
iBuBr) 
The 2-Hydroxyethyl-2-bromoisobutyrate (OH-iBuBr) was synthesized as 
described elsewhere.
[92]
  Briefly, Br-iBuA (11.4 g, 68.7 mmol) was mixed with EG (6.4 
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g, 103.1 mmol, 1.5 equivalents to hydroxyl groups) in the presence of DCC (15.1 g, 72.7 
mmol) and a catalytic amount of DMAP (0.7 g) in THF (250 mL) at room temperature 
overnight. After the removal of dicyclohexyl urea formed as a by-product, the product 
was collected as the third of the total four bands off a silica gel column by column 
chromatography using 1/4 to 2/3 v/v mixture of diethyl ether/hexane. Yield = 5.6 g 
(54.7%). Rf = 0.3 on silica (1/4 diethyl ether/hexane). 
1
H-NMR (CDCl3, ppm): 1.92 (s, 
6H, -C(CH3)2Br), 3.82 (t, 2H, -CH2OH), 4.28 (t, 2H,-OCH2CH2OH). 
13
C-NMR (CDCl3, 
ppm) 30.7, 55.8, 60.8, 67.4, 171.9. 
A.3. Synthesis of HO-POEOMA-Br macroinitiator (HO-MI) 
A series of ATRP of OEOMA was conducted in the presence of HO-iBuBr under 
various conditions. Here is an example of the detailed procedure for HO-MI with 
[OEOMA]0/[OH-iBuBr]0/[CuBr]0/[bpy]0 = 50/1/0.5/1; OH-iBuBr (0.42 g, 2.0 mmol), 
OEOMA (30.0 g, 100.0 mmol), bpy (0.32 g, 2.0 mmol), acetone (25 mL), and anisole 
(0.3 mL) were added to a 100 mL Schlenk flask. The mixture was degassed by three 
freeze-thaw cycles to remove any dissolved oxygen. The flask was filled with nitrogen 
and then CuBr (0.14 g, 1.0 mmol) was added to the frozen content. The flask was 
immediately degassed by vacuum and then was sealed under nitrogen. The mixture was 
allowed to melt and the schlenk flask was immersed in an oil bath preheated to 47 °C to 
start the polymerization. Aliquots were withdrawn at different time intervals during the 
polymerization to monitor conversion by 
1
H-NMR and molecular weight by GPC. The 
polymerization was stopped by exposing the reaction mixture to air. In order to remove 
residual copper species and unreacted monomers, the viscous polymer solutions of HO-
POEOMA-Br in acetone were precipitated (twice) into hexane (300 mL). To remove 
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copper species, the precipitate was then dissolved in THF and passed through a column 
filled with basic aluminum oxide. The polymer was isolated by evaporation of solvent via 
rotary evaporation and residual solvents were further dried in a vacuum oven at 50 C 
overnight.   
A.4. Synthesis of HO-POEOMA-b-PtBMA (HO-ABP) block copolymer 
The detailed procedure for HO-ABP with [tBMA]0/[HO-POEOMA-
Br]0/[CuBr]0/[bpy]0 = 200/1/0.5/1 is described as follows; purified, dried HO-POEOMA-
Br (1.9 g, 0.49 mmol), tBMA (14 g, 98.4 mmol), bpy (76.9 mg, 0.49 mmol), and acetone 
(14 mL) were added to a 50 mL Schlenk flask. The mixture was degassed by three 
freeze-thaw cycles to remove any dissolved oxygen. The flask was filled with nitrogen 
and then CuBr (35.3 mg, 0.25 mmol) was added to the frozen content. The flask was 
closed, evacuated with vacuum and backfilled with nitrogen once. The mixture was 
thawed and the flask was then immersed in an oil bath preheated to 47 °C to start the 
polymerization. The polymerization was stopped at 5 hrs by exposing the reaction 
mixture to air. The resulting HO-ABP was purified as described above. 
A.5. Aqueous micellization by solvent evaporation  
Dried HO-ABP (10 mg) was dissolved in THF (2 mL), and then distilled water 
was added drop-wise into copolymer mixture. The resulting dispersion was stirred for 






A.6. Determination of CMC using a NR probe 
Fluorescence measurements were performed with Nile Red (NR) to determine the 
CMC. Different dilutions were prepared from a stock solution of NR in THF at 5.0 mg 
mL
-1 
and a stock solution of HO-ABP in THF at 1.0 mg mL
-1 
to obtain a series of NR-
loaded micelles at various concentrations of HO-ABP ranging from 10
-4
 to 0.1 mg mL
-1
. 
Water (12 mL) was drop-wise added into mixtures consisting of the same amount of the 
stock solution of NR (20 µL, 0.1 mg NR) and various amounts of the stock solution of 
HO-ABP. The resulting dispersions were stirred for 12 hrs to remove THF, and then were 
subjected to filtration using 0.45 µm Polyethersulfone (PES) filters to remove excess NR. 
Their fluorescence spectra were recorded with λex = 480 nm and the fluorescence 
intensity was recorded at maximum λem = 620 nm. 
A.7. Hydrolytic cleavage of t-butyl groups of PtBMA blocks in acidic conditions  
PtBMA blocks in HO-ABP were hydrolyzed in the presence of CF3COOH in 
dichloromethane (CH2Cl2) at room temperature. Typically, HO-ABP (100 mg, 0.5 mol 
COOH) dissolved in CH2Cl2 (1.6 mL) was mixed with CF3COOH (321.6 L, 4.3 mmol) 
under stirring for 15 hrs. The degraded product was precipitated from hexane (10 mL). 
The white solids were isolated and further dried in a vacuum oven at 50 C overnight.  
A.8. pH-responsive destabilization of HO-ABP micelles at low pH 
 Using the same procedure described before, micellar dispersion was prepared at 
5 mg mL
-1
.  Three aliquots were taken from micellar dispersion. Using KHP buffer 
solution at pH = 3, pH of two aliquots were adjusted to 5 and 3.2. pH of another aliquots 
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was adjusted to pH = 7 and used as a control sample. Then their size and size distribution 
was characterized by DLS. 
A.9. Loading of NR into HO-ABP micelles 
 Purified HO-ABP (50 mg) was dissolved in a stock solution of NR in THF (5 mg 
mL
-1
, 1 mL). Then water (100 mL) was added drop-wise into the solution. The THF and 
part of water were evaporated by stirring the resulting mixture overnight to reach the final 
concentration of NR-loaded micelles at 0.5 mg mL
-1
. Then the solution was subjected to 
centrifugation (8,000 rpm × 15 min × 4 C) to precipitate non-dissolved NR. The 
supernatant was further filtered using a 0.25 m PES filter to remove residual NR. In 
order to determine the loading level of NR in micelles, an aliquot of NR-loaded micellar 
dispersion (30 mL) was taken and water was removed by a rotary evaporation. The 
remaining residues were further dried in a vacuum oven at 50 C for 2 hrs, and then 
dissolved in THF (10 mL). The UV/Vis spectrum was recorded to measure the 
absorbance at a maximum abs = 527 nm. Similar procedure was repeated three times 
with freshly-prepared NR-loaded micelles to obtain reproducible data.  
A loading level of NR (%) was determined by the weight ratio of NR 
encapsulated in micelles to dried polymers. A loading efficiency (L.E., %) was calculated 
by the weight ratio of NR encapsulated in micelles to NR initially added.  
A.10. Bioconjugation of HO-ABP with biotin  
To the dried HO-ABP (80 mg, 8 × 10
-3
 mol), was added biotin (1.9 mg, 8 × 10
-3
 
mmol), EDC (1.5 mg, 8 × 10
-3
 mmol) and DMF (3 mL). The mixture was allowed to stir 
for 48 hrs at the room temperature and was then dialyzed against aqueous NaHCO3 
 85 
 
solution for 3 days to remove free biotins. Rotary evaporation of the solution gave a 
white solid of biotinylated ABP for characterization.  
A.11. Avidin-HABA binding assay studies 
The availability of biotin on micelle was determined by Avidin-HABA assay. 
First, polymeric micelles were prepared as follow. The dried biotinylated ABP (200 mg) 
was dissolved in THF (2.5 mL) and added drop-wise into deionized water (41 mL). The 
resulting dispersion was kept under stirring overnight to remove THF, yielding an 
aqueous dispersion of micelles of biotinylated ABP at 5.0 mg mL
-1
 concentration. 
Avidin-HABA complex solution was prepared as follows; HABA (5.0 mg) was dissolved 
in water (8 ml) and undissolved species were removed using a 0.2 µm PES filter. Avidin 
(5.0 mg) was added to an aliquot of the HABA solution (5 ml). The resulting Avidin-
HABA solution was equilibrated at room temperature for 2 hrs. For control experiment, 
in a 3 mL cuvette, 1.0 g of Avidin-HABA solution was pipetted, and mixed with 1.0 g of 
water, then the absorbance was measured at abs = 500 nm (A500
Avidin-HABA
) by UV/Vis 
spectrophotometer. In another cuvette 1.0 g of Avidin-HABA solution was added and 
mixed with 1.0 g of sample (biotinylated micellar solution), the absorbance was recorded 
at abs = 500 nm (A500
Avidin-HABA+sample
). The amount of the available biotin was calculated 
by the following formula
[98]: μmol biotin/mL = (ΔA500/34) × 10. 
A.12. MTT cell viability assay 
HEK293T and HeLa cells were plated at 5 × 10
5
 cells/well into a 96-well plate 
and incubated for 24 hrs in DMEM (100 µL) containing 10% FBS. They were then 
treated with various amounts of HO-ABP micelles for another 48 hrs. Blank control 
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without micelles was run simultaneously. Cell viability was measured using CellTiter 96 
Non-Radioactive Cell Proliferation Assay kit (MTT, Promega) according to 
manufacturer’s instruction. Briefly, a solution of MTT supplied by Promega (20 µL) was 
added into each well, and then cell media were carefully removed after 4 hrs. Stop 
solution (100 L) was added into each well in order to dissolve MTT crystals, and then 
the absorbance was recorded at  = 570 nm using Powerwave HT Microplate Reader 
(Bio-Tek). Each concentration was 12-replicated. Cell viability was calculated as the 
percent ratio of absorbance of mixtures with micelles to control. 
A.13. Supporting figures 
Figure A.1. For HO-MI-3, kinetic plot (a) and evolution of molecular weight and 
molecular weight distribution over conversion (b) for ATRP of OEOMA in acetone at 
47 °C under [OEOMA]0/[HO-iBuBr]0/[CuBr]0/[bpy]0 = 50/1/0.5/1; OEOMA/acetone = 
1.5/1 wt/wt. The dotted lines in (a) are linear fits, and the straight lines in (b) are the 


















































Figure A.2. UV spectra of different concentrations of NR in THF to determine its 
extinction coefficient at max = 527 nm. 
 
Figure A.3. An example of UV spectra of HO-ABP and NR-loaded HO-ABP micelles 
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      Experimental Section of Chapter 4 
 
B.1. Materials 
2-Hydroxyethyl disulfide, 2-bromoisoburylic acid, N,N′-dicyclohexyl 
carbodiimide (DCC), 4-dimethylaminopyridine (DMAP) as a catalyst, N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDETA, >98%), copper (II) chloride (CuCl2, 
>99.99%), tin (II) 2-ethylhexanonate (Sn(Oct)2, >95%), tributyl phosphine (Bu3P, 97%), 
and anisole from Aldrich were used as received. copper(II) bromide (CuBr2, >99.99%) 
and DL-dithioerythritol (DTT, 99%) was purchased from Acros Organics. 
Oligo(propylene oxide) monononylphenyl ether acrylate (AP) with MW = 419 g mol
-1
 
and pendent PO units DP ≈ 3 and oligo(ethylene oxide) monomethyl ether methacrylate 
(OEOMA) with MW = 300 g mol
-1
 and pendent EO units DP ≈ 5 from Aldrich were 
purified by passing them through a column filled with basic alumina to remove inhibitors. 
Spectra/Por dialysis tubing (MWCO = 3,500 g mol
-1
) was purchased from SpectrumLab. 
B.2. Synthesis of bis[2-(2-bromoisobutyryloxy)ethyl] disulfide (SS-DBr) 
2-bromoisoburylic acid (12.0 g, 71.9 mmol) dissolved in tetrahydrofuran (THF, 
50 mL) was drop-wise added to a solution of 2-hydroxyethyl disulfide (5.0 g, 32.5 
mmol), DCC (14.7 g, 71.2 mmol), a catalytic amount of DMAP, and THF (130 mL) at 0 
°C over 20 min. The resulting solution was stirred at room temperature for overnight. 
White solids (dicyclohexyl urea) formed during the reaction were removed by a vacuum 
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filtration. The solvent was then removed by a rotary evaporation. For further purification, 
the product was dissolved in hexane and undissolved dicyclohexyl urea (DCU) was 
removed by vacuum filtration. The pure product was isolated by removal of hexane and 
further dried in vacuum oven at 50 °C overnight to form oily residue. 
1
H-NMR (CDCl3, 
ppm) 4.5 (t, 4H, -CH2O(O)C-), 3.0 (t, 4H, -CH2-SS-),1.9 (s, 6H, Br-C(CH3)2). 
B.3. Synthesis of ss-(PAP-Br)2 macroinitiators  
A series of ATRP of AP was conducted in the presence of SS-DBr difunctional 
initiator. The typical procedure for the preparation of ss-(PAP-Br)2 is as follows; SS-DBr 
(40.0 mg, 0.14 mmol), AP (5.8 g, 13.8 mmol), PMDETA (57.8 mL, 0.28 mmol), CuBr2 
(61.8 mg, 0.28 mmol), and acetone (4.9 mL) were added to a 25 mL Schlenk flask. The 
resulting transparent solution was deoxygenated by purging with nitrogen for 30 min at 
room temperature. The flask was immersed in an oil bath preheated to 80 °C. A nitrogen-
purged solution of Sn(Oct)2 (291.4 mg, 0.72 mmol) in anisole (0.5 mL) was added to start 
the polymerization. Aliquots were removed at different time intervals during the 
polymerization to measure conversion by 
1
H-NMR and molecular weight using GPC. 
The polymerization was stopped by exposing the catalyst to air. 
B.4. Synthesis of ss-ABP2 triblock copolymers 
Dried, purified ss-(PAP-Br)2 (Mn,theo = 10,000 g mol
-1
, 0.5 g, 0.05 mmol), 
OEOMA (1.5 g, 5.0 mmol), PMDETA (20.9 mL, 0.10 mmol), CuCl2 (13.4 mg, 0.10 
mmol), and anisole (1.3 mL) were added to a 25 mL Schlenk flask. The resulting 
transparent solution was deoxygenated by purging with nitrogen for 30 min at room 
temperature. The flask was immersed in an oil bath preheated to 80 °C. A nitrogen-
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purged solution of Sn(Oct)2 (105 mg, 0.26 mmol) in anisole (0.3 mL) was added to start 
the polymerization. Aliquots were removed at different time intervals during the 
polymerization to measure conversion and molecular weight using GPC. The 
polymerization was stopped by exposing the catalyst to air. For purification of ss-ABP2, 
anisole was removed from reaction mixture by rotary evaporation. The residues were 
dissolved in THF and dialyzed using a dialysis tubing with MWCO = 3,500 g mol
-1
 
(SpectrumLab) over a mixture of MeOH/water (5/5 v/v) to remove unreacted OEOMA. 
The GPC trace suggests that < 5% unreacted OEOMA remained in the purified ss-ABP2. 
B.5. Aqueous micellization by solvent evaporation  
An aliquot of the purified, dried ss-ABP2 (92 mg) was dissolved in THF (2.6 mL). 
The clear polymer solution (0.30 mL) was drop-wise added into deionized water (10 
mL). The resulting dispersion was kept under stirring overnight to remove THF, yielding 
colloidally stable micellar dispersions at 1mg mL
-1
 concentration.  
B.6. Determination of CMC of ss-ABP2 in water by tensiometry 
An aliquot of the purified, dried ss-ABP2 (20 mg) was dissolved in THF (1.0 mL).  
The clear polymer solution was drop-wise added into deionized water (20 mL). The 
resulting dispersion was kept under stirring overnight to remove THF, allowing for 
colloidally stable micellar dispersion. The final concentration of the dispersion was 
calculated to be 1.4 mg mL
-1
. Then, aliquots of the aqueous stock solution were diluted 
with different amounts of deionized water to form a series of aqueous solutions of ss-
ABP2 at different concentrations from 10
-3
 to 1.4 mg mL
-1
. A tensiometry was used to 
measure the osmotic pressure (mN/m) of the solutions as follows; an aliquot of each 
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solution (600 μL) was carefully placed on each well and equilibrated before 
measurements. The tensiometer was calibrated using air and water. 
B.7. Degradation of ss-ABP2 triblock copolymers and micelles 
An aliquot of purified, dried ss-ABP2 (50 mg) was dissolved in THF (5 mL). To 
the mixture was added Bu3P (0.85 mL) defined as the ratio of Bu3P/disulfide = 1/1. The 
mixture was magnetically stirred and aliquots of the mixture were injected into GPC to 
determine molecular weight of degraded products. 
For micellar dispersion, an aliquot of micellar dispersion at 2.3 mg mL
-1
 (100 mL) 
was diluted with water (2.0 mL). The amount of disulfide linkages in micelles can be 
calculated to be 18.1 nmol using Mn,theo = 12,700 g mol
-1
 of ss-ABP2. An aliquot of the 
micellar dispersion (1.0 mL) was mixed with an aqueous stock solution of DTT (0.5 mg 
mL
-1
, 2.7 mL) defined as the ratio of DTT/disulfide = 1/1 under magnetic stirring. 












B.8. Supporting figures 
Figure B.1. 
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      Experimental Section of Chapter 5 
 
C.1. Materials 
PEO-b-PHMssEt block copolymer was synthesized by Dr. Q. Zhang.
[64]
 
Doxorubicin hydrochloride (DOX.HCl, > 98%), L-glutathione (GSH) reduced form, 
triethylamine (Et3N, > 99.5 %) and dimethylformamide (DMF) were purchased from 
Aldrich and used as received. Spectra/Por dialysis tubing (MWCO = 12,000 g mol
-1
) was 
purchased from SpectrumLab. For cell viability assay, Dulbecco’s modified eagle 
medium (DMEM) and fetal bovine serum (FBS) were used as received from Wisent and 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, a yellow 
tetrazolium) was used as received from Promega. 4',6-diamidino-2-phenylindole (DAPI) 
and mounting medium were used as received from Aldrich.  
C.2. Aqueous micellization by dialysis method 
Water (9 mL) was added drop-wise to a clear solution of PEO-b-PHMssEt (10 
mg) dissolved in DMF (2 mL). The resulting mixture was stirred for 2 hrs, and then 
dialyzed in a dialysis tubing (MWCO = 12,000 g mol
-1
) against water for 3 days to 
remove DMF. The outer water (500 mL) was changed twice a day, yielding colloidally-






C.3. Preparation of DOX-loaded micelles  
Similar procedure for aqueous micellization through the dialysis method was 
used. For the preparation of the sample of MDOX-1, water (5 mL) was added dropwise 
to the solution consisting of the purified, dried PEO-b-PHMssEt (20 mg), DOX (1 mg), 
and Et3N (3 mol equivalent to DOX) in DMF (2 mL). The resulting dispersion was 
dialyzed over water (500 mL) for 5 days, yielding DOX-loaded micellar dispersion at 2.6 
mg mL
-1
 concentration. For the MDOX-2 at 1.7 mg mL
-1
, a similar procedure was used 
except for the use of increasing amounts of PEO-b-PHMssEt (20 mg), DOX (2 mg), 
DMF (3 mL), and water (10 mL). 
C.4. Determination of loading level of DOX using UV/Vis spectroscopy 
A calibration curve of absorbance (A) at max = 480 nm over various 
concentrations of DOX in DMF was first constructed as follows. A stock solution of 
DOX in DMF (1 mg mL
-1
, 1.7 mmol L
-1
) was first prepared by dissolving DOX (1 mg, 
1.7 μmol) in DMF (1 mL). Aliquots of the stock solution were then diluted with DMF to 
form a series of solutions of DOX ranging from 5.6 to19.5 μmol L-1. Their UV/Vis 
spectra (ex = 480 nm) were recorded. To determine the loading level of DOX in DOX-
loaded micelles, aliquots of DOX-loaded micellar dispersion (1 mL) were taken. After 
the removal of water using a rotary evaporation, the residues of DOX and copolymers 
were dissolved in DMF (2 mL) to form clear solution. Their UV/Vis spectra were 
recorded and the loading level of DOX was calculated by the weight ratio of loaded DOX 









C.5. GSH-triggered destabilization of PEO-b-PHMssEt micelles 
Aliquots of aqueous micellar dispersion (1 mg mL
-1
, 10 mL) were mixed with 
GSH (30 mg, 97 μmol, 10 mM) under stirring. An aliquot was taken to analyze their size 
distributions using DLS.  
C.6. GSH-triggered release of DOX from DOX-loaded micelles 
Aliquots of DOX-loaded micellar dispersion (2.5 mg mL
-1
, 3 mL) were 
transferred into a dialysis tubing (MWCO = 12,000 g mol
-1
) and immersed in aqueous 
KH2PO4 buffer solution (50 mL, pH = 7.0) as a control and 10 mM aqueous GSH 
solution buffered with KH2PO4 at pH = 7.0 under stirring. The absorbance of DOX in 
outer water was recorded at an interval of 5 min using a UV/Vis spectrometer equipped 
with an external probe at  = 497 nm. For quantitative analysis, DOX (20 μg) was 
dissolved in aqueous GSH solution buffered with KH2PO4 (10 mM, pH = 7.0). The 
UV/Vis spectrum of DOX in the solution was recorded and the absorbance at 497 nm 
was used for normalization.   
C.7. Cell viability using MTT assay 
HEK293T and HeLa cells were plated at 5 × 10
5
 cells/well into a 96-well plate 
and incubated for 24 hrs in DMEM (100 µL) containing 10% FBS. They were then 
incubated with various concentrations of micellar dispersions of PEO-b-PHMssEt for 48 
hrs. Blank controls without micelles (cells only) were run simultaneously. Cell viability 
was measured using CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay kit 
(Promega) according to manufacturer’s instruction. Briefly, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) solutions (15 µL) was added into each well and 
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after 4 hrs incubation the medium containing unreacted MTT was carefully removed. The 
formed blue formazan crystals were dissolved in 100 μL per well stop solution, and the 
absorbance was measured at 570 nm using Powerwave HT Microplate Reader (Bio-Tek). 
Viability was calculated as the percent ratio of absorbance of mixtures with micelles to 
control (cells only). 
C.8. Intracellular DOX release and HeLa cells viability 
HeLa cells were plated at 1 × 10
5
 cells/ well into a 96-well plate and incubated for 
24 hrs in 100 µL complete medium. They were then incubated with different amounts of 
DOX-loaded micellar dispersion (2.8 mg mL
-1
) for 48 hrs.  Cells only without micelles 
were run simultaneously as blank controls. Viability was calculated as the percent ratio of 
absorbance of mixtures with micelles to control (cells only). 
C.9. Cellular uptake using flow cytometry and Confocal laser scanning 
microscopy (CLSM)  
C.9.1. Flow cytometry 
Cells plated at 5 × 10
5
 cells/well into a 6-well plate and incubated for 24 hrs in 
DMEM (2 mL) and then incubated with DOX-loaded micelles (200 µL for DOX = 1.9 µg 
mL
-1
) at 37 ºC for 1 hr.  After culture medium was removed, cells were washed with PBS 
buffer three times and then treated with trypsin. The cells were suspended in DMEM 
(300 µL) for flow cytometry measurements. Data analysis was performed by means of a 
BD FACSCANTO II flow cytometer and BD FACSDiva software.  
 98 
 
C.9.2. Confocal laser scanning microscopy (CLSM) 
HeLa cells plated at 2 × 10
5
 cells/well into a 24-well plate and incubated for 24 
hrs in DMEM (100 µL) and then incubated with DOX-loaded micelles (DOX = 5.1 µg 
mL
-1
) at 37 ºC for 24 hrs.  After culture medium was removed, cells were washed with 
PBS buffer three times. After the removal of supernatants, the cells were fixed with cold 
methanol (-20 ºC) for 20 min at 4 ºC. The slides were rinsed with TBST (tris-buffered 
saline tween-20) for three times. Cells were stained with 2-(4-amidinophenl)-6-
indolecarbamidine (DAPI) for 5 min. The fluorescence images were obtained using a 
LSM 510 Meta/Axiovert 200 (Carl Zeiss, Jena, Germany). 
C.10. Supporting figures 
Figure C.1. Evolution of z-average diameter of PEO-b-PHMssEt micelles in aqueous 10 
mM GSH solution over time. 
 




































Figure C.3. Overlaid UV spectra (a) and absorbance at λmax = 480 nm (b) of DOX at 
various concentrations (µmol L
-1
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Figure C.4. Absorption (––) and emission (- - -) spectra of 0.01 mg mL–1 free DOX, and 







Figure C.5. Absorption spectra of MTT and commercially prepared MTT-formazan 
dissolved in DMSO. Also shown is the spectrum of MTT-formazan produced by 
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